<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Issues Mol Biol</journal-id><journal-id journal-id-type="iso-abbrev">Curr Issues Mol Biol</journal-id><journal-id journal-id-type="pmc-domain-id">4181</journal-id><journal-id journal-id-type="pmc-domain">cimb</journal-id><journal-id journal-id-type="publisher-id">cimb</journal-id><journal-title-group><journal-title>Current Issues in Molecular Biology</journal-title></journal-title-group><issn pub-type="ppub">1467-3037</issn><issn pub-type="epub">1467-3045</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10296855</article-id><article-id pub-id-type="pmcid-ver">PMC10296855.1</article-id><article-id pub-id-type="pmcaid">10296855</article-id><article-id pub-id-type="pmcaiid">10296855</article-id><article-id pub-id-type="pmid">37367073</article-id><article-id pub-id-type="doi">10.3390/cimb45060324</article-id><article-id pub-id-type="publisher-id">cimb-45-00324</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Antioxidant Intake and Biomarkers of Asthma in Relation to Smoking Status&#8212;A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0619-4136</contrib-id><name name-style="western"><surname>Alsharairi</surname><given-names initials="NA">Naser A.</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Wu</surname><given-names initials="C">Chingyuan</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-cimb-45-00324">Heart, Mind &amp; Body Research Group, Griffith University, Gold Coast P.O. Box 4222, QLD, Australia; <email>naser.alsharairi@gmail.com</email></aff><pub-date pub-type="epub"><day>10</day><month>6</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2023</year></pub-date><volume>45</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">439219</issue-id><fpage>5099</fpage><lpage>5117</lpage><history><date date-type="received"><day>26</day><month>5</month><year>2023</year></date><date date-type="rev-recd"><day>07</day><month>6</month><year>2023</year></date><date date-type="accepted"><day>09</day><month>6</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>10</day><month>06</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>28</day><month>06</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-27 14:25:21.070"><day>27</day><month>05</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 by the author.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="cimb-45-00324.pdf"/><abstract><p>Asthma is considered a chronic inflammatory disorder associated with airway hyperresponsiveness (AHR). Increased oxidative stress (OS) is a clinical feature of asthma, which promotes the inflammatory responses in bronchial/airway epithelial cells. Smokers and nonsmokers with asthma have been shown to have increases in several OS and inflammatory biomarkers. However, studies suggest significant differences in OS and inflammation biomarkers between smokers and nonsmokers. A few studies suggest associations between antioxidant intake from diet/supplements and asthma in patients with different smoking status. Evidence is lacking on the protective role of antioxidant vitamin and/or mineral consumption against asthma by smoking status with respect to inflammation and OS biomarkers. Therefore, the aim of this review is to highlight current knowledge regarding the relations between antioxidant intake, asthma, and its associated biomarkers, according to smoking status. This paper can be used to guide future research directions towards the health consequences of antioxidant intake in smoking and nonsmoking asthmatics.</p></abstract><kwd-group><kwd>asthma</kwd><kwd>antioxidant</kwd><kwd>vitamins</kwd><kwd>minerals</kwd><kwd>supplements</kwd><kwd>biomarkers</kwd><kwd>oxidative stress</kwd><kwd>inflammation</kwd><kwd>smokers</kwd><kwd>nonsmokers</kwd></kwd-group><funding-group><funding-statement>This review received no financial support.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-cimb-45-00324"><title>1. Introduction</title><p>Smoking is regarded as a significant risk factor for asthma progression [<xref rid="B1-cimb-45-00324" ref-type="bibr">1</xref>]. The number of asthma deaths due to smoking in 2019 was higher in men than in women [<xref rid="B1-cimb-45-00324" ref-type="bibr">1</xref>,<xref rid="B2-cimb-45-00324" ref-type="bibr">2</xref>]. Asthma is characterized by airway hyperresponsiveness (AHR) and reversible airflow obstruction, which is attributed to increased airway smooth muscle (ASM) contraction [<xref rid="B3-cimb-45-00324" ref-type="bibr">3</xref>,<xref rid="B4-cimb-45-00324" ref-type="bibr">4</xref>,<xref rid="B5-cimb-45-00324" ref-type="bibr">5</xref>]. Asthma is associated predominantly with mast/CD4<sup>+</sup> cells, T lymphocytes and eosinophils. Mucous hypersecretion, luminal obstruction, goblet cell hyperplasia, and thickening of bronchial walls are commonly observed features in asthma [<xref rid="B3-cimb-45-00324" ref-type="bibr">3</xref>].</p><p>Tobacco smoke is associated with reduced lung function measured as forced expiratory volume in 1 s (FEV<sub>1</sub>) and increased bronchial hyperresponsiveness in smokers with asthma [<xref rid="B6-cimb-45-00324" ref-type="bibr">6</xref>]. Asthmatic patients who smoked &#8805;10 pack/year had a rapid decline in FEV<sub>1</sub> and forced vital capacity (FVC) compared with those who smoked &lt;10 pack/year after 12-year follow-up [<xref rid="B7-cimb-45-00324" ref-type="bibr">7</xref>]. Secondhand smoke (SHS) exposure has been linked to asthma risk in active and/or former smokers [<xref rid="B8-cimb-45-00324" ref-type="bibr">8</xref>]. Exposure to SHS in public places was associated with a marked decrease in peak expiratory flow rate (PEFR) and FVC in asthmatic smokers [<xref rid="B9-cimb-45-00324" ref-type="bibr">9</xref>]. The risk of asthma among nonsmokers who were exposed to SHS has increased in a large adult-onset asthma population with 16 years of follow-up [<xref rid="B10-cimb-45-00324" ref-type="bibr">10</xref>].</p><p>Tobacco smoke consists of a range of toxic chemicals (e.g., benzopyrene, acrolein, crotonaldehyde, phenols, ammonia, nitrosamines, hydrocarbons, aromatic amines), which are potentially harmful to human bronchial epithelial cells (HBECs), causing airway inflammation by increasing mitochondrial reactive oxygen species (ROS) and pro-inflammatory interleukin (IL)-8 cytokine production [<xref rid="B11-cimb-45-00324" ref-type="bibr">11</xref>,<xref rid="B12-cimb-45-00324" ref-type="bibr">12</xref>]. Downregulation of microRNAs in lung fibroblasts of smokers may affect its function due to aberrant DNA methylation at specific sites [<xref rid="B13-cimb-45-00324" ref-type="bibr">13</xref>]. Moderate asthma was associated with lung inflammation, and this response is related to reduced expression of microRNA target genes such as I-miR-146a [<xref rid="B14-cimb-45-00324" ref-type="bibr">14</xref>]. Cigarette smoke extract (CSE) exposure in HBECs results in increased oxidative stress (OS) and pro-inflammatory cytokines IL-6, IL-8, and tumor necrosis factor &#945; (TNF-&#945;) by the activation of several inflammatory signaling pathways, including the transcription factor-kappaB (NF-&#954;B), extracellular signal-regulated kinases (ERK 1/2), c-Jun N-terminal kinase (JNK), and mitogen-activated protein kinases (MAPKs) [<xref rid="B15-cimb-45-00324" ref-type="bibr">15</xref>]. Tobacco smoke alters immune responses in the lung, triggering asthma by activating Toll-like receptors (e.g., TLR-2 and TLR-4)-stimulated pro-inflammatory cytokine production and increasing total serum immunoglobulin E (IgE) levels in airway epithelial cells [<xref rid="B16-cimb-45-00324" ref-type="bibr">16</xref>]. In asthmatic patients, exposure to environmental tobacco smoke (ETS) results in oxidant/antioxidant imbalance, which leads to increased pro-inflammatory biomarkers as assessed by increased TNF&#945;, IL-6, and IL-8 [<xref rid="B16-cimb-45-00324" ref-type="bibr">16</xref>]. Evidence suggests that nicotine is not carcinogenic, but it may affect the airway epithelial cells of asthmatic smokers by activating nitrosamine 4(methylnitrosamino)-1-(3&#8211;pyridyl)-1-butanone (NNK), which binds to the &#945;7 nicotinic acetylcholine receptor (&#945;7nAChR), leading to AHR and inflammation by upregulating the &#945;7nAChR-mediated signaling pathways [<xref rid="B17-cimb-45-00324" ref-type="bibr">17</xref>].</p><p>The genetic variants&#8211;tobacco smoke exposure interaction has been shown to increase asthma risk in smokers and nonsmokers. Evidence of the interaction between variants of rs9969775 on chromosome 9, rs5011804 on chromosome 12, and active tobacco smoking was reported in asthmatic adults [<xref rid="B18-cimb-45-00324" ref-type="bibr">18</xref>]. Genetic variants of NLR Family CARD Domain Containing 4 (NLRP4) inflammasome are implicated in asthma exacerbation in current and former adult smokers as evidenced by high genotype-specific expression of rs16986718G [<xref rid="B19-cimb-45-00324" ref-type="bibr">19</xref>]. The presence of mutant AG/GG genotype for <italic toggle="yes">CD14</italic> rs2569190 and rs13150331 (TLR) polymorphism in asthmatic adult smokers increases the risk of the disease [<xref rid="B20-cimb-45-00324" ref-type="bibr">20</xref>]. Asthmatic nonsmokers carrying allele homozygotes of rs1384006 C&#8201; &gt; &#8201;T of the OS responsive kinase 1 (<italic toggle="yes">OXSR1</italic>) gene are at higher asthma exacerbation risk than asthmatic smokers [<xref rid="B21-cimb-45-00324" ref-type="bibr">21</xref>].</p><p>Few studies have evaluated evidence-based treatment for asthma in smokers. Pycnogenol<sup>&#174;</sup>, a herbal dietary supplement-based extract manufactured by Horphag Research (Geneva, Switzerland) and derived from French <italic toggle="yes">Pinus pinaster</italic> bark, is regarded as an option for the treatment of asthma when used in combination with the inhalation corticosteroid (ICS) therapy, resulting in improvement of asthma symptoms [<xref rid="B22-cimb-45-00324" ref-type="bibr">22</xref>]. Asthmatic smokers have ICS insensitivity as compared to asthmatic nonsmokers and are less responsive to the benefits of ICS treatment alone. Alterations of inflammatory phenotypes and glucocorticoid receptors and the reduction of histone deacetylase (HDAC) activity are considered potential mechanisms of corticosteroid insensitivity in asthmatic smokers [<xref rid="B23-cimb-45-00324" ref-type="bibr">23</xref>,<xref rid="B24-cimb-45-00324" ref-type="bibr">24</xref>]. The combination of ICS therapy and a long-acting &#946;2 adrenergic (LABA) displays a better clinical improvement for smoking and nonsmoking asthmatics than using ICS alone [<xref rid="B25-cimb-45-00324" ref-type="bibr">25</xref>,<xref rid="B26-cimb-45-00324" ref-type="bibr">26</xref>]. The use of nicotine replacement therapy, varenicline or bupropion, may significantly improve lung function and AHR in asthmatic smokers [<xref rid="B25-cimb-45-00324" ref-type="bibr">25</xref>].</p><p>There is still a significant amount of uncertainty in the safety and efficacy of dietary supplements for the treatment of lung diseases among smokers and/or nonsmokers due to the limited number randomized controlled trials (RCTs) [<xref rid="B27-cimb-45-00324" ref-type="bibr">27</xref>,<xref rid="B28-cimb-45-00324" ref-type="bibr">28</xref>]. Thus, there is a need to focus on the role of antioxidants in smoking-related asthma risk. A recent review investigating the effects of dietary antioxidant intake on lung cancer (LC) risk among smokers and nonsmokers suggests that dietary vitamins (C, D, E, and carotenoids) and minerals (zinc and copper) may exert protective effects against cigarette smoke (CS)-induced OS and/or inflammation. However, dietary retinol and iron intake did not provide any protection, and research suggests caution in recommending these for LC treatment [<xref rid="B29-cimb-45-00324" ref-type="bibr">29</xref>]. There is a direct association between LC and asthma in smokers [<xref rid="B30-cimb-45-00324" ref-type="bibr">30</xref>,<xref rid="B31-cimb-45-00324" ref-type="bibr">31</xref>]. Given that smoking is considered a risk factor for asthma through increased levels of OS and inflammatory cytokine production [<xref rid="B17-cimb-45-00324" ref-type="bibr">17</xref>], targeting dietary/supplement-derived antioxidants might help our understanding of their role in protecting bronchial epithelial cells against CS-induced-OS/inflammatory biomarkers in smokers and nonsmokers. This paper explores this connection to gain insight into the health consequences of antioxidant consumption and makes recommendations for future studies. To date, there have been no reviews to evaluate antioxidant intake and the biomarkers of OS and inflammation in asthma, according to smoking status.</p></sec><sec sec-type="methods" id="sec2-cimb-45-00324"><title>2. Methods</title><p>A literature review in the PubMed/MEDLINE database and Google Scholar was conducted for English language studies published between 1 January 2000 and 30 April 2023. The following search terms were used: asthma, diet, supplements, antioxidant, vitamins, minerals, OS, lipid peroxidation (LP), inflammation, biomarkers, antioxidant/oxidant enzymes, bronchial/airway epithelial cells, smoking, smokers, and nonsmokers. Studies focusing on the chronic obstructive pulmonary disease (COPD) were excluded, as the diagnostic biomarkers in asthma are different from both COPD and the asthma-COPD overlap. All studies relevant to the search terms were included, and the search was not restricted to a particular study design.</p></sec><sec id="sec3-cimb-45-00324"><title>3. Antioxidant Intake and Asthma in Relation to Smoking Status</title><p>Studies investigating the associations between antioxidant intake and asthma according to smoking status are limited. Smokers with low dietary vitamin C (VC) intake had chronic bronchitis symptoms associated with asthma compared with those who had higher intake [<xref rid="B32-cimb-45-00324" ref-type="bibr">32</xref>]. According to quartiles of carotenoid dietary/supplement intake (carotene, lycopene, and lutein with zeaxanthin), the risk of asthma was reported to be lower in the fourth quartile (&#8805;165.59 &#956;g/kg per day) than the first quartile (&lt;41.43 (&#956;g/kg per day) among current smokers, ex-smokers, and nonsmokers with asthma [<xref rid="B33-cimb-45-00324" ref-type="bibr">33</xref>]. One trial revealed no effects of 6 weeks of supplemental vitamin E (VE) on AHR in nonsmokers with asthma [<xref rid="B34-cimb-45-00324" ref-type="bibr">34</xref>]. Supplementation with selenium (Se) had no significant improvement in asthma-related quality of life (QoL) and lung function regardless of smoking status [<xref rid="B35-cimb-45-00324" ref-type="bibr">35</xref>]. These findings suggest that dietary VC and carotenoids intake may reduce asthma in smokers and/or nonsmokers. Supplementation with VE and Se had no effect on asthma in smokers and nonsmokers. The associations between antioxidant intake and asthma risk according to smoking status are summarized in <xref rid="cimb-45-00324-t001" ref-type="table">Table 1</xref>.</p></sec><sec id="sec4-cimb-45-00324"><title>4. Biomarkers of OS and Inflammation in Relation to Smoking Status</title><p>OS is regarded as the major contributor to CS-induced airway inflammation [<xref rid="B36-cimb-45-00324" ref-type="bibr">36</xref>]. Evidence from many studies, mostly derived from case-control design, has shown that CS activates OS by augmenting airway inflammation in smoking and nonsmoking asthmatics.</p><sec id="sec4dot1-cimb-45-00324"><title>4.1. Biomarkers of OS</title><sec><title>Case-Control Studies</title><p>Asthmatic current smokers showed increased serum levels of malondialdehyde (MDA) and decreased levels of the ferric-reducing ability of plasma (FRAP) [<xref rid="B37-cimb-45-00324" ref-type="bibr">37</xref>]. Higher MDA levels in exhaled breath condensate (EBC) have been reported in active smoking asthmatics than in their ex-smoking and nonsmoking counterparts [<xref rid="B38-cimb-45-00324" ref-type="bibr">38</xref>]. The levels of protein carbonyls and peroxynitrite in plasma were reported to be higher in current smoking asthmatics than in their ex-smoking and nonsmoking counterparts [<xref rid="B39-cimb-45-00324" ref-type="bibr">39</xref>]. Smoking asthmatics with a lower FEV<sub>1</sub> have higher erythrocyte antioxidant enzyme activity, including superoxide dismutase (SOD) and disulfide/oxidized glutathione (GSH) activity, than nonsmoking patients with asthma and healthy controls. Increased SOD and GSH in smoking asthmatics may not protect airway epithelial cells against the harmful effects of free radicals. SOD and GSH activities were found to be higher in nonsmoking asthmatics than healthy controls [<xref rid="B40-cimb-45-00324" ref-type="bibr">40</xref>]. Nonsmoking asthmatics demonstrated increased levels of nitrite (NO<sub>2</sub><sup>&#8722;</sup>), protein carbonyls, lipid peroxide, SOD activity, and decreased protein sulfhydrils and glutathione peroxidase (GPx) activity in leukocytes and red blood cells [<xref rid="B41-cimb-45-00324" ref-type="bibr">41</xref>]. High sputum GSH and NO<sub>2</sub><sup>&#8722;</sup> levels were reported in nonsmokers with stable and acute asthma [<xref rid="B42-cimb-45-00324" ref-type="bibr">42</xref>].</p><p>Overall findings suggest that the oxidant/antioxidant imbalance derived by CS is likely to exist in smoking and nonsmoking asthmatics. OS biomarkers are increased in current and nonsmokers, but the increase in the enzymatic antioxidants in smokers may be insufficient to protect bronchial/airway epithelial cells against oxidative damage. <xref rid="cimb-45-00324-t002" ref-type="table">Table 2</xref> shows the OS biomarkers in smoking and nonsmoking asthmatics.</p></sec></sec><sec id="sec4dot2-cimb-45-00324"><title>4.2. Biomarkers of Inflammation</title><sec id="sec4dot2dot1-cimb-45-00324"><title>4.2.1. Case-Control Studies</title><p>Fractional exhaled nitric oxide (FeNO) was reported in lower levels in smoking asthmatics than nonsmoking asthmatics and healthy controls. This reduction is accompanied by increased numbers of sputum eosinophils [<xref rid="B43-cimb-45-00324" ref-type="bibr">43</xref>]. Smoking asthmatics had lower FeNO levels than their nonsmoking counterparts, but this decrease does not appear to reflect improvement of asthma control [<xref rid="B44-cimb-45-00324" ref-type="bibr">44</xref>]. Low levels of FeNO were observed in current/ex-smokers with severe asthma compared to nonsmokers with mild-moderate asthma. High FeNO levels and blood eosinophil count provide a moderate prediction of type 2 high status in severe asthmatic nonsmokers [<xref rid="B45-cimb-45-00324" ref-type="bibr">45</xref>]. Increased levels of FeNO, eosinophils, and neutrophils have been observed in the airways of current nonsmoking asthmatics [<xref rid="B46-cimb-45-00324" ref-type="bibr">46</xref>]. Compared to active smokers with asthma, nonsmokers with asthma had higher FeNO levels [<xref rid="B47-cimb-45-00324" ref-type="bibr">47</xref>].</p><p>Eotaxin-1 in EBC was associated with blood eosinophil count, FeNO value, and serum ECP in nonsmoking asthmatics [<xref rid="B48-cimb-45-00324" ref-type="bibr">48</xref>]. Eotaxin was found at higher levels in the sputum of smokers than nonsmokers with asthma. Sputum and serum IL-5 levels were found to be higher in nonsmoking asthmatics than in smoking asthmatics and healthy controls. High BALF eotaxin-1 was associated with increased BALF eosinophil and neutrophil counts and percentages [<xref rid="B49-cimb-45-00324" ref-type="bibr">49</xref>]. Comparatively greater levels of sputum IL-1&#946;, IL-5, and Interleukin 18 receptor 1 (IL-18R1) have been reported in current/ex-smoking severe asthmatics compared to healthy controls. Bronchoscopy and Bronchoalveolar Lavavge Fluid (BALF) levels of eotaxin-1 were observed to be high in nonsmoking asthmatics. Higher sputum levels of IL-4, IL-5, IL-1&#946;, Interleukin 1 receptor-like 1 (IL-1RL1), Interleukin 1 receptor, type I (IL-1R1), IL-1R2, IL-18R1, and NLRP3 were detected in nonsmoking severe asthmatics compared to mild-moderate asthmatics and healthy controls [<xref rid="B50-cimb-45-00324" ref-type="bibr">50</xref>].</p><p>Higher sputum eosinophils, eosinophilic cationic protein (ECP), neutrophils, and IL-8 levels were observed in asthmatic smokers compared to healthy nonsmokers, which were associated with FEV<sub>1</sub> and neutrophil count. Compared to healthy nonsmokers, nonsmoking asthmatics demonstrated higher sputum ECP and eosinophil levels [<xref rid="B51-cimb-45-00324" ref-type="bibr">51</xref>]. Serum periostin has been observed in higher levels in nonsmokers than smokers with asthma [<xref rid="B52-cimb-45-00324" ref-type="bibr">52</xref>]. High serum periostin, TNF&#945;, IL-4, IL-5, and the chitinase-like protein YKL-40 levels, as well as low serum IL-37 levels, were associated with exacerbated asthma in nonsmokers [<xref rid="B53-cimb-45-00324" ref-type="bibr">53</xref>]. Asthmatic smokers demonstrated increased sputum levels of neutrophils, and decreased levels of eosinophils compared to asthmatic nonsmokers. Both asthmatic smokers and nonsmokers showed increased sputum levels of eosinophils compared to healthy smokers. High IL-18 levels in the sputum of nonsmoking asthmatics were associated with FEV<sub>1</sub> decline [<xref rid="B54-cimb-45-00324" ref-type="bibr">54</xref>]. Current and ex-smokers with asthma have higher frequencies of sputum type 3 innate lymphoid cells (ILC3), which has been identified as a biomarker of airway eosinophilic inflammation, and peripheral blood CD45RO-expressing memory-like ILC3s compared with nonsmokers counterparts. ILC3 was associated with M1 alveolar macrophage and circulating neutrophil counts [<xref rid="B55-cimb-45-00324" ref-type="bibr">55</xref>]. High levels of peripheral blood ILC2, FeNO, blood eosinophils, and serum IgE were associated with sputum eosinophil counts in eosinophilic asthmatic nonsmokers compared to healthy controls [<xref rid="B56-cimb-45-00324" ref-type="bibr">56</xref>]. Higher serum high-sensitivity C-reactive protein (hs-CRP) levels were reported in nonsmokers with mild-to-moderate asthma than healthy controls and were associated with sputum neutrophils/eosinophils and impaired FEV<sub>1</sub> [<xref rid="B57-cimb-45-00324" ref-type="bibr">57</xref>]. Nonsmoking asthmatics showed higher levels of hs-CRP and blood eosinophils compared to nonsmoking healthy controls [<xref rid="B58-cimb-45-00324" ref-type="bibr">58</xref>]. A number of inflammation biomarkers, including hs-CRP, serum total IgE, and blood/sputum eosinophils and neutrophils have been identified in higher proportions in smokers and nonsmokers with severe asthma compared to healthy nonsmokers [<xref rid="B59-cimb-45-00324" ref-type="bibr">59</xref>]. Higher levels of Matrix metallopeptidase (MMP-12), C-X-C motif chemokine ligand-8 (CXCL8), neutrophil elastase, azurocidin 1 (AZU-1), and pro-platelet basic protein (PPBP) were observed in the sputum of ex-smoking asthmatics, which are linked to neutrophilic inflammation. Nonsmokers with asthma have significantly elevated sputum and blood eosinophil counts [<xref rid="B60-cimb-45-00324" ref-type="bibr">60</xref>].</p></sec><sec id="sec4dot2dot2-cimb-45-00324"><title>4.2.2. Cross-Sectional Studies</title><p>FeNO levels were reported to be high in ex-smoking and nonsmoking asthmatics. Low FeNO levels were associated with increased nitric oxide synthase (NOS2) mRNA levels in current smokers, but not in ex-smokers/nonsmokers. Current and ex-smoking asthmatics exhibit higher NADPH oxidase 2 (NOX2) mRNA levels [<xref rid="B61-cimb-45-00324" ref-type="bibr">61</xref>]. Current smokers with severe asthma have lower FeNO value, sputum eosinophils/neutrophils, and serum-specific IgE levels than nonsmokers. Ex-smokers compared with nonsmokers have higher sputum neutrophils, blood eosinophils, and lower serum-specific IgE levels [<xref rid="B62-cimb-45-00324" ref-type="bibr">62</xref>]. FeNO levels have been observed higher in nonsmokers than current and ex-smokers with asthma. Current and ex-smokers compared with nonsmokers had higher number of blood eosinophils [<xref rid="B63-cimb-45-00324" ref-type="bibr">63</xref>]. FeNO values were higher in smokers and nonsmokers with uncontrolled asthma treated and/or treated with ICS than those with partly/well-controlled asthma [<xref rid="B64-cimb-45-00324" ref-type="bibr">64</xref>]. Current smoking was associated with small airway obstruction in asthma. Interestingly, increased levels of serum IgE were associated with reduced risk of small airway obstruction in nonsmoking asthmatics compared to current and ex-smoking counterparts [<xref rid="B65-cimb-45-00324" ref-type="bibr">65</xref>].</p></sec><sec id="sec4dot2dot3-cimb-45-00324"><title>4.2.3. Cohort Studies</title><p>Higher FeNO levels have been observed in nonsmokers than smokers with asthma, which are associated with FEV<sub>1</sub> and FEV<sub>1</sub>/FVC decline over 20-year follow-up [<xref rid="B66-cimb-45-00324" ref-type="bibr">66</xref>]. In asthmatic patients with persistent obstruction where nonsmokers represented the vast majority, high sputum periostin levels were associated with FEV<sub>1</sub> decline and high sputum eosinophil counts, resulting in increased FeNO value, blood eosinophil counts and transforming growth factor beta 1 (TGF-&#946;1) over 2-year follow-up [<xref rid="B67-cimb-45-00324" ref-type="bibr">67</xref>].</p><p>It can be suggested that current smoking, ex-smoking, and nonsmoking asthmatics exhibit higher levels of inflammation biomarkers, which have the potential to increase the risk. <xref rid="cimb-45-00324-t003" ref-type="table">Table 3</xref> shows the OS and inflammatory biomarkers in nonsmoking asthmatics.</p></sec></sec></sec><sec id="sec5-cimb-45-00324"><title>5. Potential Effects of Antioxidant on CS-Induced Asthma Biomarkers</title><sec id="sec5dot1-cimb-45-00324"><title>5.1. Antioxidant Vitamins</title><sec id="sec5dot1dot1-cimb-45-00324"><title>5.1.1. Vitamin A</title><p>Vitamin A (VA) derived from dietary animal-source foods has an active metabolite retinoic acid (RA), which binds retinoic acid receptors (RARs) and retinoid X receptors (RXRs) with high affinity, resulting in a regulation of ASM cell proliferation in asthma [<xref rid="B68-cimb-45-00324" ref-type="bibr">68</xref>]. Low RA levels in ASM cells increases the severity of asthma [<xref rid="B69-cimb-45-00324" ref-type="bibr">69</xref>]. Human ASM cells treated with RAR&#947;-specific agonist and all-<italic toggle="yes">trans</italic> RA (ATRA) lead to the inhibition of platelet-derived growth factor (PDGF)-induced activator protein-1 (AP-1) regulated genes, including MMP8 and MMP9 [<xref rid="B69-cimb-45-00324" ref-type="bibr">69</xref>]. TGF-&#946; increases the expression of ATRA and 9-<italic toggle="yes">cis</italic> RA in the ASM cells of patients with severe asthma compared with those with mild-to-moderate asthma, which results in upregulation of the mRNA of &#946;1-integrin, MMP-9, and hepatocyte growth factor receptor (HGF-R). Treatment with anti-TGF-&#946;1 monoclonal antibody in the presence of ATRA/9-<italic toggle="yes">cis</italic> RA reduces the levels of MMP-9 mRNA in ASM cells. This concludes that TGF-&#946; increases ASM cell inflammation in response to exaggerated RA receptor expression, which may lead to airway epithelial repair defects in severe asthma [<xref rid="B70-cimb-45-00324" ref-type="bibr">70</xref>]. Administration of ATRA suppresses PDGF-induced ASM cell migration via RAR-RXR heterodimer activation and Serine-threonine kinase/Phosphatidylinositol-3 kinase (Akt/PI3K) signaling pathway inhibition [<xref rid="B71-cimb-45-00324" ref-type="bibr">71</xref>]. Treatment with RA improves barrier strength of HBECs by reducing TNF-&#945; and IL-6-induced airway barrier leaks and occluded din/claudin-4 [<xref rid="B72-cimb-45-00324" ref-type="bibr">72</xref>]. ATRA treatment inhibits airway inflammation by suppressing Th2 and Th17-related cytokines (IL-4, IL-5, IL-17A), neutrophils, eosinophils, macrophages, and lymphocytes counts [<xref rid="B73-cimb-45-00324" ref-type="bibr">73</xref>]. Administration of ATRA and 9-<italic toggle="yes">cis</italic> RA suppresses IL-4-induced eotaxin mRNA expression in HBECs [<xref rid="B74-cimb-45-00324" ref-type="bibr">74</xref>]. 9-<italic toggle="yes">cis</italic>-RA treatment results in reversing RAR-beta (RAR-&#946;) expression loss in the HBECs of ex-smokers, suggesting that RA may be considered as a potential agent against asthma risk in smokers [<xref rid="B75-cimb-45-00324" ref-type="bibr">75</xref>]. Nonsmoker patients with lung emphysema treated with ATRA resulted in improvement in lung function and reduction of airway inflammation through the inhibition of TNF-&#945; and IL-3 plasma levels [<xref rid="B76-cimb-45-00324" ref-type="bibr">76</xref>]. Overall findings suggest that VA exerts anti-inflammatory effects on ASM/HBECs cells.</p></sec><sec id="sec5dot1dot2-cimb-45-00324"><title>5.1.2. Carotenoids</title><p>&#946;-carotene, also termed provitamin A/non-polar carotenoid, and other non-provitamin A/polar carotenoids (e.g., lycopene, lutein, zeaxanthin) are natural pigments, present primarily in fruits and vegetables, which have been shown to exert anti-inflammatory/OS agents for several diseases [<xref rid="B77-cimb-45-00324" ref-type="bibr">77</xref>], including asthma [<xref rid="B78-cimb-45-00324" ref-type="bibr">78</xref>]. It has been shown that supplementation of HBECs &#8220;BEAS-2B&#8221; with &#946;-carotene does not promote membrane LP/lactate dehydrogenase (LDH) leakage and &#945;-tocopherol/GSH depletion caused by gas phase smoke [<xref rid="B79-cimb-45-00324" ref-type="bibr">79</xref>]. &#946;-carotene exerts a protective effect in HBECs treated with CS-induced lung carcinogen benzo[a]pyrene (BaP) through increasing RAR-&#946; expression [<xref rid="B80-cimb-45-00324" ref-type="bibr">80</xref>].</p><p>Lycopene exerts a therapeutic effect against asthma by reducing eosinophilic infiltrates and Th2-mediated cytokines IL-4 and IL-5 production in the airways [<xref rid="B81-cimb-45-00324" ref-type="bibr">81</xref>]. Treatment with apo-10&#8242;-lycopenoic acid, an active metabolite of lycopene, increases accumulation of nuclear factor-E2 related factor 2 (Nrf2)-mediated heme-oxygenase-1 (HO-1) activation and intracellular GSH levels and decreases intracellular ROS levels and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-induced LDH production in BEAS-2B [<xref rid="B82-cimb-45-00324" ref-type="bibr">82</xref>]. Treatment of BEAS-2B with &#946;-cryptoxanthin (BCX) reduces inflammation, as indicated by increased sirtuin1 (SIRT1) protein levels and inhibited lipopolysaccharide (LPS)-induced TNF-&#945;, MMP2/9, IL-6, and monocyte chemoattractant protein-1 (MCP-1) mRNA levels [<xref rid="B83-cimb-45-00324" ref-type="bibr">83</xref>]. BCX supplementation of ferrets led to inhibited CS-induced NF-kB, AP-1, and TNF&#945; expression in the lungs [<xref rid="B84-cimb-45-00324" ref-type="bibr">84</xref>]. These findings suggest that lycopene and BCX may protect HBECs against CS-induced inflammation and/or OS biomarkers.</p></sec><sec id="sec5dot1dot3-cimb-45-00324"><title>5.1.3. Vitamin C and E</title><p>Epidemiological studies regarding the role of antioxidant VC and VE in the treatment of asthma have demonstrated inconsistent findings [<xref rid="B85-cimb-45-00324" ref-type="bibr">85</xref>]. The ascorbic acid-supplemented diet has been shown to reduce the bronchoconstrictive responses in asthmatic patients, as demonstrated by decreasing post-exercise FeNO, FEV<sub>1</sub>, and urinary 9&#945;, 11&#946;-PGF2 levels [<xref rid="B86-cimb-45-00324" ref-type="bibr">86</xref>]. Administration of VC to ovalbumin (OVA)-sensitized and challenged asthmatic mice attenuates airway inflammation by reducing eosinophilic infiltration into BALF [<xref rid="B87-cimb-45-00324" ref-type="bibr">87</xref>].</p><p>VE and curcumin treatment reduces BaP-induced ROS levels by downregulating poly[ADP-ribose] polymerase 1 (PARP-1) and protein 53 (p53) activity in BEAS-2B [<xref rid="B88-cimb-45-00324" ref-type="bibr">88</xref>]. Treatment with natural-source d-&#945;-tocopheryl acetate increases plasma levels of &#945;-tocopherol isoform of VE in atopic asthmatics, resulting in reduced BAL levels of IL-3 and IL-4 [<xref rid="B89-cimb-45-00324" ref-type="bibr">89</xref>]. In allergic asthmatic adults, &#947;-tocopherol treatment led to suppression of LPS-induced TNF&#945;, IL-6, and IL-1&#946; production from peripheral blood monocytes [<xref rid="B90-cimb-45-00324" ref-type="bibr">90</xref>]. In human and mice models, supplementation with &#947;-tocopherol reduced LPS-induced sputum percentages of neutrophils and eosinophils [<xref rid="B91-cimb-45-00324" ref-type="bibr">91</xref>]. &#947;-tocopherol supplementation reduces sputum mucins, neutrophils, and eosinophils in mild asthmatics [<xref rid="B92-cimb-45-00324" ref-type="bibr">92</xref>]. VE-supplemented diet results in decreased IL-4 and IL-5 levels in the murine lungs [<xref rid="B93-cimb-45-00324" ref-type="bibr">93</xref>]. Treatment with VE attenuates AHR through reducing OS and inflammatory biomarkers. VE decreases LPS-induced IL-5, IL-13 levels, H2O2-mediated ROS production, eosinophils, neutrophils, and restores the serum activity of GSH and SOD [<xref rid="B94-cimb-45-00324" ref-type="bibr">94</xref>]. Administration of VE reduces asthma by decreasing IL-4 levels, ROS production, serum IgE levels, and increasing GSH levels [<xref rid="B95-cimb-45-00324" ref-type="bibr">95</xref>]. VE treatment attenuates allergic asthma by reducing levels of peroxynitrite, NO<sub>2</sub><sup>&#8722;</sup>, IgE, eotaxin, IgE, TGF-&#946;1, IL-4, IL-5, and IL-13 [<xref rid="B96-cimb-45-00324" ref-type="bibr">96</xref>]. Administration of supplemental &#945;-and &#947;-tocopherol resulted in reduced BALF IL-5, IL-12, and IL-13 levels [<xref rid="B97-cimb-45-00324" ref-type="bibr">97</xref>]. This suggests that VC may reduce airway inflammation, while VE may have protective effects against both OS and inflammatory biomarkers.</p></sec><sec id="sec5dot1dot4-cimb-45-00324"><title>5.1.4. Vitamin D</title><p>Evidence from in vitro and in vivo studies has supported the protective role of VD against asthma, by which VD supplementation reduces airway inflammation and improves lung function in asthmatic patients [<xref rid="B98-cimb-45-00324" ref-type="bibr">98</xref>]. VD treatment has been shown to decrease IL-6 and CXCL8 levels in cultured HBECs from asthmatic donors [<xref rid="B99-cimb-45-00324" ref-type="bibr">99</xref>]. In asthmatic patients, supplementation with VD increases serum anti-inflammatory IL-10, and decreases serum levels of IgE, eosinophil, IL-5, IL-9, and IL-13 [<xref rid="B100-cimb-45-00324" ref-type="bibr">100</xref>]. Supplementation with VD reduces asthmatic airway inflammation, as evidenced by decreased levels of IL-4 in BALF and NO<sub>2</sub><sup>&#8722;</sup> in serum and BALF [<xref rid="B101-cimb-45-00324" ref-type="bibr">101</xref>]. VD treatment decreases the index of airway collagen deposition, mucus reserve, and increases autophagy-related protein expression levels of hypoxia-inducible factor 1 alpha (HIF-1&#945;) and neurogenic locus notch homolog protein 1 (Notch1), resulting in reduced airway inflammation associated with IL-6 and IL-17 cytokines [<xref rid="B102-cimb-45-00324" ref-type="bibr">102</xref>]. Supplementation of VD reduces AHR and IgE levels in BALF and serum in asthmatic mice [<xref rid="B103-cimb-45-00324" ref-type="bibr">103</xref>]. Administration of VD to VD-deficient mice with asthma reduces BALF levels of neutrophil, eosinophil, IL-5, and IL-13 [<xref rid="B104-cimb-45-00324" ref-type="bibr">104</xref>]. It has been demonstrated that 1,25(OH)(2)D(3) supplementation reduces serum OVA-specific IgE levels, accompanied with increased serum levels of IL-10 via inhibition of NF-kB signaling pathway [<xref rid="B105-cimb-45-00324" ref-type="bibr">105</xref>]. VD supplementation reduces BALF eosinophil numbers, BALF IL-6, IL-17, TNF-&#945; levels, and increase BALF IL-10 levels [<xref rid="B106-cimb-45-00324" ref-type="bibr">106</xref>]. VD was found to reduce serum levels of IL-6, IL-1&#946;, TNF-&#945;, and increase serum levels of IL-10 through downregulating high mobility group box 1 proteins (HMGB1)/TLR4/NF-&#954;B signaling pathway [<xref rid="B107-cimb-45-00324" ref-type="bibr">107</xref>]. Overall findings suggest that VD may have anti-inflammatory/anti-oxidants effects on HBECs due to its ability to reduce inflammatory biomarkers, which may therefore be involved in CS-induced asthma treatment.</p></sec></sec><sec id="sec5dot2-cimb-45-00324"><title>5.2. Antioxidant Minerals</title><sec id="sec5dot2dot1-cimb-45-00324"><title>5.2.1. Iron</title><p>Iron (Fe) is a critical mineral implicated in free radical production, which has a detrimental effect on asthma, as evident by increasing plasma Fe levels in HBECs, which result in a significant increase in OS and LP [<xref rid="B108-cimb-45-00324" ref-type="bibr">108</xref>,<xref rid="B109-cimb-45-00324" ref-type="bibr">109</xref>]. IL-6 was shown to enhance ferroptosis in HBECs, identified as regulated cell death, by disrupting iron homeostasis and increasing ROS and MDA-dependent LP [<xref rid="B110-cimb-45-00324" ref-type="bibr">110</xref>]. In mice sensitized to OVA, high expression of HO-1, an enzyme responsible for degrading heme into free iron, was found to be associated with airway inflammation via increased levels of IL-5, IL-13, and eosinophilia in the lung tissue [<xref rid="B111-cimb-45-00324" ref-type="bibr">111</xref>].</p><p>High serum levels of saturation of transferrin and ferritin, as indices of Fe homeostasis, were associated with airway obstruction in smokers and nonsmokers with the lowest FEV<sub>1</sub>/FVC ratio [<xref rid="B112-cimb-45-00324" ref-type="bibr">112</xref>]. Exposure to tobacco smoke condensate alters iron homeostasis in human respiratory epithelial cells by increasing serum Fe and ferritin accumulation in the lungs of smokers [<xref rid="B113-cimb-45-00324" ref-type="bibr">113</xref>]. This suggests that Fe is associated with increased asthma risk and should not be recommended for smoking asthmatics.</p></sec><sec id="sec5dot2dot2-cimb-45-00324"><title>5.2.2. Zinc, Selenium, and Copper</title><p>Evidence from in vivo and in vitro studies suggests that zinc (Zn), Se, and copper (Cu) play a significant role in reducing asthma and protecting airway epithelial cells against OS and inflammatory biomarkers [<xref rid="B114-cimb-45-00324" ref-type="bibr">114</xref>]. Treatment of airway epithelial (HEp-2) cells with toxic copper oxide nanoparticles (CuONPs) results in induced OS by increasing ROS and 8-isoprostane production [<xref rid="B115-cimb-45-00324" ref-type="bibr">115</xref>]. CuONPs increase AHR and the production of ROS and pro-inflammatory cytokines via activating of MAPK signaling in OVA-induced asthmatic mice [<xref rid="B116-cimb-45-00324" ref-type="bibr">116</xref>]. Cu and Zn are key components of SOD, which results in a reduction of OS. The plasma levels of Se, Cu, Zn, and a cytosolic antioxidant enzyme, copper&#8211;zinc-superoxide dismutase (CuZnSOD), were reported to be lower in asthmatics than in healthy controls [<xref rid="B117-cimb-45-00324" ref-type="bibr">117</xref>,<xref rid="B118-cimb-45-00324" ref-type="bibr">118</xref>,<xref rid="B119-cimb-45-00324" ref-type="bibr">119</xref>]. Se was found to be associated with decreased levels of OS biomarker plasma thiobarbituric acid-reactive substances (TBARS), hs-CRP levels and CD4/CD8 lymphocyte ratios [<xref rid="B118-cimb-45-00324" ref-type="bibr">118</xref>]. An experimental study has demonstrated that Zn chelator N,N,N&#8242;,N&#8242;-tetrakis(2-pyridylmethyl)ethylenediamine inhibits TNF&#945;-induced eotaxin mRNA expression in BEAS-2B cells [<xref rid="B120-cimb-45-00324" ref-type="bibr">120</xref>]. Zn supplementation reduced BALF eosinophils and attenuated airway inflammation-induced solute carrier family 39 members 1 and 14 (ZIP1, ZIP14) [<xref rid="B121-cimb-45-00324" ref-type="bibr">121</xref>]. Administration of Zn to mice with OVA-induced allergic asthma led to reduced monocytes, neutrophils, and eosinophils in BALF, MCP-1, and eotaxin protein production [<xref rid="B122-cimb-45-00324" ref-type="bibr">122</xref>]. This suggests that Zn may have potential antioxidant effects against inflammation biomarkers.</p><p>The potential effect of antioxidant vitamins and minerals on CS-induced asthma biomarkers was shown in <xref rid="cimb-45-00324-t004" ref-type="table">Table 4</xref>.</p></sec></sec></sec><sec id="sec6-cimb-45-00324"><title>6. Concluding Remarks</title><p>CS is associated with biomarkers of OS and systemic inflammation in HBECs. Literature has shown that OS and inflammation have a significant role in the pathogenesis of asthma in current smokers, ex-smokers, and nonsmokers. There were significant differences in asthma biomarkers between smokers and nonsmokers. OS biomarkers MDA, FRAP, protein carbonyls, and peroxynitrite, and inflammation biomarkers ILC2/3, MMP-12, CXCL8, neutrophil elastase, AZU-1, and PPBP were found to associate with asthma in smokers, but not in nonsmokers. However, OS biomarkers NO<sub>2</sub><sup>&#8722;</sup>, lipid peroxide, protein sulfhydrils, and inflammatory biomarkers TNF&#945;, IL-4, IL-37, IL-1&#946;, IL-1RL1, IL-1R1, NLRP3, and TGF-&#946;1 showed positive association with asthma in nonsmokers, but not in smokers. Current smokers with asthma have higher levels of OS biomarkers than nonsmokers and are thus at a heightened state of OS. The activity of the enzymatic antioxidant defense in smoking asthmatics may not adequately protect the HBECs against oxidative damage.</p><p>Evidence from a few studies suggests that dietary VC and carotenoid intake are associated with reduced asthma risk in smokers and/or nonsmokers. Supplementing VE and Se had no effects on improving lung function in smoking asthmatics.</p><p>Several in vivo and in vitro studies have demonstrated the protective effects of antioxidant vitamin and mineral against asthma biomarkers. VA, VC, BCX, and Zn might protect HBECs against inflammatory biomarkers, while VE, VD, and lycopene might provide protection against both OS and inflammatory biomarkers. Fe has adverse effects on HBECs and should be avoided for smoking and nonsmoking asthmatics.</p><p>The potential effects of antioxidant on CS-induced asthma biomarkers in smoking and nonsmoking asthmatics are difficult to determine, given a limited number of human studies. VA and carotenoids may trigger a protective effect against asthma in smokers and/or nonsmokers. However, VC, VE, VD, and Zn may have protective potential against asthma biomarkers. Such effects lead to the conclusion that these antioxidants might have beneficial effects in reducing asthma in smokers and nonsmokers, given that smoking and nonsmoking asthmatics are susceptible to CS-induced OS and inflammatory biomarkers.</p><p>The mechanisms by which antioxidant vitamins and minerals might be effective in protecting HBECs against asthma biomarkers in smokers and nonsmokers have not been fully elucidated. Human studies on the exact mechanisms (signaling pathways) linking the antioxidant intake to asthma in smokers and nonsmokers have not yet been confirmed. Few signaling pathways might be involved, as demonstrated by in vivo models (e.g., TLR4/NF-&#954;B signaling pathway in VD). Further human studies are needed to explore the mechanisms by which antioxidants might be effective in protecting HBECs against asthma biomarkers in smokers and nonsmokers.</p><p>More studies on smokers and nonsmokers are needed to determine the associations between antioxidant intake from both diet and supplements and asthma biomarkers. Studies included in this review did not determine whether nonsmokers with asthma are affected by SHS exposure. Thus, further studies are required to examine whether antioxidant intake in nonsmoking asthmatics could protect against CS-induced asthma biomarkers.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The author declares no conflict of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">AHR</td><td align="left" valign="middle" rowspan="1" colspan="1">Airway hyperresponsiveness</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Akt</td><td align="left" valign="middle" rowspan="1" colspan="1">Serine-threonine kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AP-1</td><td align="left" valign="middle" rowspan="1" colspan="1">Activator protein-1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ASM</td><td align="left" valign="middle" rowspan="1" colspan="1">Airway smooth muscle</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ATRA</td><td align="left" valign="middle" rowspan="1" colspan="1">All-<italic toggle="yes">trans</italic> RA</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AZU-1</td><td align="left" valign="middle" rowspan="1" colspan="1">Azurocidin 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BALF</td><td align="left" valign="middle" rowspan="1" colspan="1">Bronchoalveolar Lavavge Fluid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BaP</td><td align="left" valign="middle" rowspan="1" colspan="1">Benzo[a]pyrene</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BCX</td><td align="left" valign="middle" rowspan="1" colspan="1">&#946;-cryptoxanthin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">COPD</td><td align="left" valign="middle" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CS</td><td align="left" valign="middle" rowspan="1" colspan="1">Cigarette smoke</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CSE</td><td align="left" valign="middle" rowspan="1" colspan="1">Cigarette smoke extract</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cu</td><td align="left" valign="middle" rowspan="1" colspan="1">Copper</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CuONPs</td><td align="left" valign="middle" rowspan="1" colspan="1">Copper oxide nanoparticles</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CuZnSOD</td><td align="left" valign="middle" rowspan="1" colspan="1">Zinc-superoxide dismutase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CXCL</td><td align="left" valign="middle" rowspan="1" colspan="1">C-X-C motif chemokine ligand</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EBC</td><td align="left" valign="middle" rowspan="1" colspan="1">Exhaled breathe condensate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ECP</td><td align="left" valign="middle" rowspan="1" colspan="1">Eosinophilic cationic protein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ERK</td><td align="left" valign="middle" rowspan="1" colspan="1">Extracellular signal-regulated kinases</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ETS</td><td align="left" valign="middle" rowspan="1" colspan="1">Environmental tobacco smoke</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fe</td><td align="left" valign="middle" rowspan="1" colspan="1">Iron</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FeNO</td><td align="left" valign="middle" rowspan="1" colspan="1">Fractional exhaled nitric oxide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FEV<sub>1</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">Forced expiratory volume in 1 s</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FRAP</td><td align="left" valign="middle" rowspan="1" colspan="1">Ferric reducing ability of plasma</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FVC</td><td align="left" valign="middle" rowspan="1" colspan="1">Forced vital capacity</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GPx</td><td align="left" valign="middle" rowspan="1" colspan="1">Glutathione peroxidase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GSH</td><td align="left" valign="middle" rowspan="1" colspan="1">Reduced glutathione</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">Hydrogen peroxide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HBECs</td><td align="left" valign="middle" rowspan="1" colspan="1">Human bronchial epithelial cells</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HDAC</td><td align="left" valign="middle" rowspan="1" colspan="1">Histone deacetylase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HGFR</td><td align="left" valign="middle" rowspan="1" colspan="1">Hepatocyte growth factor receptor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HIF-1&#945;</td><td align="left" valign="middle" rowspan="1" colspan="1">Hypoxia-inducible factor 1 alpha</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HMGB1</td><td align="left" valign="middle" rowspan="1" colspan="1">Mobility group box 1 protein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HO-1</td><td align="left" valign="middle" rowspan="1" colspan="1">Heme-oxygenase-1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">hs-CRP</td><td align="left" valign="middle" rowspan="1" colspan="1">High-sensitivity C-reactive protein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ICS</td><td align="left" valign="middle" rowspan="1" colspan="1">Inhalation corticosteroid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IgE</td><td align="left" valign="middle" rowspan="1" colspan="1">Immunoglobulin E</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL</td><td align="left" valign="middle" rowspan="1" colspan="1">Interleukin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ILC</td><td align="left" valign="middle" rowspan="1" colspan="1">Innate lymphoid cell</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL-18R1</td><td align="left" valign="middle" rowspan="1" colspan="1">Interleukin 18 receptor 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL-1RL1</td><td align="left" valign="middle" rowspan="1" colspan="1">Interleukin 1 receptor-like 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">8-iso-PGF<sub>2&#945;</sub></td><td align="left" valign="middle" rowspan="1" colspan="1"><sub>I</sub>soprostane-8-iso prostaglandin F<sub>2&#945;</sub></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">JNK</td><td align="left" valign="middle" rowspan="1" colspan="1">c-Jun N-terminal kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LABA</td><td align="left" valign="middle" rowspan="1" colspan="1">Long-acting &#946;2 adrenergic</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LC</td><td align="left" valign="middle" rowspan="1" colspan="1">Lung cancer</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LDH</td><td align="left" valign="middle" rowspan="1" colspan="1">Lactate dehydrogenase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LP</td><td align="left" valign="middle" rowspan="1" colspan="1">Lipid peroxidation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LPS</td><td align="left" valign="middle" rowspan="1" colspan="1">Lipopolysaccharide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAPKs</td><td align="left" valign="middle" rowspan="1" colspan="1">Mitogen-activated protein kinases</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MCP-1</td><td align="left" valign="middle" rowspan="1" colspan="1">Monocyte chemoattractant protein-1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MDA</td><td align="left" valign="middle" rowspan="1" colspan="1">Malondialdehyde</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MMP</td><td align="left" valign="middle" rowspan="1" colspan="1">Matrix metallopeptidases</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MPO</td><td align="left" valign="middle" rowspan="1" colspan="1">Myeloperoxidase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#945;7nAChR</td><td align="left" valign="middle" rowspan="1" colspan="1">&#945;7 nicotinic acetylcholine receptor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NF-&#954;B</td><td align="left" valign="middle" rowspan="1" colspan="1">Nuclear transcription factor-kappaB</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NLRP</td><td align="left" valign="middle" rowspan="1" colspan="1">NLR Family CARD Domain Containing</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NNK</td><td align="left" valign="middle" rowspan="1" colspan="1">Nitrosamine 4(methylnitrosamino)-1-(3&#8211;pyridyl)-1-butanone</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NO<sub>2</sub><sup>&#8722;</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">Nitrite</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NOS</td><td align="left" valign="middle" rowspan="1" colspan="1">Nitric oxide synthase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Notch1</td><td align="left" valign="middle" rowspan="1" colspan="1">Neurogenic locus notch homolog protein 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NOX2</td><td align="left" valign="middle" rowspan="1" colspan="1">NADPH oxidase 2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Nrf2</td><td align="left" valign="middle" rowspan="1" colspan="1">Nuclear factor-E2 related factor 2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">OS</td><td align="left" valign="middle" rowspan="1" colspan="1">Oxidative stress</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">OVA</td><td align="left" valign="middle" rowspan="1" colspan="1">Ovalbumin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">OXSR1</td><td align="left" valign="middle" rowspan="1" colspan="1">Oxidative stress responsive kinase 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">P53</td><td align="left" valign="middle" rowspan="1" colspan="1">Protein 53</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PARP-1</td><td align="left" valign="middle" rowspan="1" colspan="1">Poly[ADP-ribose] polymerase 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PDGF</td><td align="left" valign="middle" rowspan="1" colspan="1">Platelet-derived growth factor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PEFR</td><td align="left" valign="middle" rowspan="1" colspan="1">Peak expiratory flow rate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PGF2</td><td align="left" valign="middle" rowspan="1" colspan="1">Prostaglandin F2 </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PI3K</td><td align="left" valign="middle" rowspan="1" colspan="1">Phosphatidylinositol-3 kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PPBP</td><td align="left" valign="middle" rowspan="1" colspan="1">Pro-platelet basic protein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">QoL</td><td align="left" valign="middle" rowspan="1" colspan="1">Quality of life</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RA</td><td align="left" valign="middle" rowspan="1" colspan="1">Retinoic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RARs</td><td align="left" valign="middle" rowspan="1" colspan="1">Retinoic acid receptors</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RDBPC</td><td align="left" valign="middle" rowspan="1" colspan="1">Randomized double blind placebo control</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RXRs</td><td align="left" valign="middle" rowspan="1" colspan="1">Retinoid X receptors</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RCTs</td><td align="left" valign="middle" rowspan="1" colspan="1">Randomised controlled trials</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ROS</td><td align="left" valign="middle" rowspan="1" colspan="1">Reactive oxygen species</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Se</td><td align="left" valign="middle" rowspan="1" colspan="1">Selenium</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SHS</td><td align="left" valign="middle" rowspan="1" colspan="1">Secondhand smoke</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SIRT1</td><td align="left" valign="middle" rowspan="1" colspan="1">Sirtuin1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SLC-39</td><td align="left" valign="middle" rowspan="1" colspan="1">Solute carrier family 39</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SOD</td><td align="left" valign="middle" rowspan="1" colspan="1">Superoxide dismutase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TBARS</td><td align="left" valign="middle" rowspan="1" colspan="1">Thiobarbituric acid reactive substances</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TGF-&#946;1</td><td align="left" valign="middle" rowspan="1" colspan="1">Transforming growth factor beta 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Th</td><td align="left" valign="middle" rowspan="1" colspan="1">T-helper</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TLR</td><td align="left" valign="middle" rowspan="1" colspan="1">Toll-like receptors</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TNF-&#945;</td><td align="left" valign="middle" rowspan="1" colspan="1">Tumor necrosis factor &#945;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TNFRSF11A</td><td align="left" valign="middle" rowspan="1" colspan="1">TNF receptor superfamily member 11a</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VA</td><td align="left" valign="middle" rowspan="1" colspan="1">Vitamin A</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VC</td><td align="left" valign="middle" rowspan="1" colspan="1">Vitamin C</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VD</td><td align="left" valign="middle" rowspan="1" colspan="1">Vitamin D</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VE</td><td align="left" valign="middle" rowspan="1" colspan="1">Vitamin E</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Zn</td><td align="left" valign="middle" rowspan="1" colspan="1">Zinc</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-cimb-45-00324"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Z.J.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>B.</given-names></name></person-group><article-title>Smoking: A leading factor for the death of chronic respiratory diseases derived from Global Burden of Disease Study 2019</article-title><source>BMC Pulm. Med.</source><year>2022</year><volume>22</volume><elocation-id>149</elocation-id><pub-id pub-id-type="doi">10.1186/s12890-022-01944-w</pub-id><pub-id pub-id-type="pmid">35443660</pub-id><pub-id pub-id-type="pmcid">PMC9019969</pub-id></element-citation></ref><ref id="B2-cimb-45-00324"><label>2.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Institute for Health Metrics and Evaluation</collab></person-group><article-title>Global Burden of Disease 2017</article-title><year>2017</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://vizhub.healthdata.org/gbd-compare/#" ext-link-type="uri">http://vizhub.healthdata.org/gbd-compare/#</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-03-06">(accessed on 6 March 2023)</date-in-citation></element-citation></ref><ref id="B3-cimb-45-00324"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aoshiba</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nagai</surname><given-names>A.</given-names></name></person-group><article-title>Differences in airway remodeling between asthma and chronic obstructive pulmonary disease</article-title><source>Clin. Rev. Allergy Immunol.</source><year>2004</year><volume>27</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1385/CRIAI:27:1:035</pub-id><pub-id pub-id-type="pmid">15347849</pub-id></element-citation></ref><ref id="B4-cimb-45-00324"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doeing</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Solway</surname><given-names>J.</given-names></name></person-group><article-title>Airway smooth muscle in the pathophysiology and treatment of asthma</article-title><source>J. Appl. Physiol.</source><year>2013</year><volume>114</volume><fpage>834</fpage><lpage>843</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00950.2012</pub-id><pub-id pub-id-type="pmid">23305987</pub-id><pub-id pub-id-type="pmcid">PMC3633438</pub-id></element-citation></ref><ref id="B5-cimb-45-00324"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kume</surname><given-names>H.</given-names></name></person-group><article-title>Role of airway smooth muscle in inflammation related to asthma and COPD</article-title><source>Adv. Exp. Med. Biol.</source><year>2021</year><volume>1303</volume><fpage>139</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">33788192</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-030-63046-1_9</pub-id></element-citation></ref><ref id="B6-cimb-45-00324"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimoda</surname><given-names>T.</given-names></name><name name-style="western"><surname>Obase</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kishikawa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Iwanaga</surname><given-names>T.</given-names></name></person-group><article-title>Influence of cigarette smoking on airway inflammation and inhaled corticosteroid treatment in patients with asthma</article-title><source>Allergy Asthma Proc.</source><year>2016</year><volume>37</volume><fpage>50</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.2500/aap.2016.37.3944</pub-id><pub-id pub-id-type="pmid">27401308</pub-id></element-citation></ref><ref id="B7-cimb-45-00324"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tommola</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ilmarinen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Haanp&#228;&#228;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kankaanranta</surname><given-names>T.</given-names></name><name name-style="western"><surname>Niemel&#228;</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kankaanranta</surname><given-names>H.</given-names></name></person-group><article-title>The effect of smoking on lung function: A clinical study of adult-onset asthma</article-title><source>Eur. Respir. J.</source><year>2016</year><volume>48</volume><fpage>1298</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1183/13993003.00850-2016</pub-id><pub-id pub-id-type="pmid">27660515</pub-id></element-citation></ref><ref id="B8-cimb-45-00324"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korsb&#230;k</surname><given-names>N.</given-names></name><name name-style="western"><surname>Landt</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Dahl</surname><given-names>M.</given-names></name></person-group><article-title>Second-hand smoke exposure associated with risk of respiratory symptoms, asthma, and COPD in 20,421 adults from the General Population</article-title><source>J. Asthma Allergy</source><year>2021</year><volume>14</volume><fpage>1277</fpage><lpage>1284</lpage><pub-id pub-id-type="doi">10.2147/JAA.S328748</pub-id><pub-id pub-id-type="pmid">34737580</pub-id><pub-id pub-id-type="pmcid">PMC8560177</pub-id></element-citation></ref><ref id="B9-cimb-45-00324"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keogan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sunday</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tigova</surname><given-names>O.</given-names></name><name name-style="western"><surname>Fern&#225;ndez</surname><given-names>E.</given-names></name><name name-style="western"><surname>L&#243;pez</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Gallus</surname><given-names>S.</given-names></name><name name-style="western"><surname>Semple</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tzortzi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Boffi</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Lung function changes in patients with chronic obstructive pulmonary disease (COPD) and asthma exposed to secondhand smoke in outdoor areas</article-title><source>J. Asthma</source><year>2021</year><volume>58</volume><fpage>1169</fpage><lpage>1175</lpage><pub-id pub-id-type="doi">10.1080/02770903.2020.1766062</pub-id><pub-id pub-id-type="pmid">32441557</pub-id></element-citation></ref><ref id="B10-cimb-45-00324"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coogan</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Castro-Webb</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>O&#8217;Connor</surname><given-names>G.T.</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>L.</given-names></name></person-group><article-title>Active and passive smoking and the incidence of asthma in the Black Women&#8217;s Health Study</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>2015</year><volume>191</volume><fpage>168</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1164/rccm.201406-1108OC</pub-id><pub-id pub-id-type="pmid">25387276</pub-id><pub-id pub-id-type="pmcid">PMC4347433</pub-id></element-citation></ref><ref id="B11-cimb-45-00324"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van der Toorn</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rezayat</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kauffman</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Bakker</surname><given-names>S.J.L.</given-names></name><name name-style="western"><surname>Gans</surname><given-names>R.O.B.</given-names></name><name name-style="western"><surname>Ko&#235;ter</surname><given-names>G.H.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>A.M.K.</given-names></name><name name-style="western"><surname>Van Oosterhout</surname><given-names>A.J.M.</given-names></name><name name-style="western"><surname>Slebos</surname><given-names>D.-J.</given-names></name></person-group><article-title>Lipid-soluble components in cigarette smoke induce mitochondrial production of reactive oxygen species in lung epithelial cells</article-title><source>Am. J. Physiol. Lung. Cell Mol. Physiol.</source><year>2009</year><volume>297</volume><fpage>L109</fpage><lpage>L114</lpage><pub-id pub-id-type="doi">10.1152/ajplung.90461.2008</pub-id><pub-id pub-id-type="pmid">19411310</pub-id><pub-id pub-id-type="pmcid">PMC2711811</pub-id></element-citation></ref><ref id="B12-cimb-45-00324"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>G.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X.</given-names></name></person-group><article-title>Chemical constituents of tobacco smoke induce the production of interleukin-8 in human bronchial epithelium, 16HBE cells</article-title><source>Tob. Induc. Dis.</source><year>2016</year><volume>14</volume><fpage>24</fpage><pub-id pub-id-type="doi">10.1186/s12971-016-0089-4</pub-id><pub-id pub-id-type="pmid">27436995</pub-id><pub-id pub-id-type="pmcid">PMC4950078</pub-id></element-citation></ref><ref id="B13-cimb-45-00324"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ong</surname><given-names>J.</given-names></name><name name-style="western"><surname>van den Berg</surname><given-names>A.</given-names></name><name name-style="western"><surname>Faiz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Boudewijn</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Timens</surname><given-names>W.</given-names></name><name name-style="western"><surname>Vermeulen</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Kok</surname><given-names>K.</given-names></name><name name-style="western"><surname>Terpstra</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>van den Berge</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Current smoking is associated with decreased expression of miR-335&#8211;5p in parenchymal lung fibroblasts</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>5176</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20205176</pub-id><pub-id pub-id-type="pmid">31635387</pub-id><pub-id pub-id-type="pmcid">PMC6829537</pub-id></element-citation></ref><ref id="B14-cimb-45-00324"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mirra</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cione</surname><given-names>E.</given-names></name><name name-style="western"><surname>Spaziano</surname><given-names>G.</given-names></name><name name-style="western"><surname>Esposito</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sorgenti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Granato</surname><given-names>E.</given-names></name><name name-style="western"><surname>Cerqua</surname><given-names>I.</given-names></name><name name-style="western"><surname>Muraca</surname><given-names>L.</given-names></name><name name-style="western"><surname>Iovino</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gallelli</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Circulating microRNAs expression profile in lung inflammation: A preliminary study</article-title><source>J. Clin. Med.</source><year>2022</year><volume>11</volume><elocation-id>5446</elocation-id><pub-id pub-id-type="doi">10.3390/jcm11185446</pub-id><pub-id pub-id-type="pmid">36143090</pub-id><pub-id pub-id-type="pmcid">PMC9500709</pub-id></element-citation></ref><ref id="B15-cimb-45-00324"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cipollina</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fasola</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cristaldi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Patella</surname><given-names>B.</given-names></name><name name-style="western"><surname>Inguanta</surname><given-names>R.</given-names></name><name name-style="western"><surname>Vilasi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aiello</surname><given-names>G.</given-names></name><name name-style="western"><surname>La Grutta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Torino</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Cellular and molecular signatures of oxidative stress in bronchial epithelial cell models injured by cigarette smoke extract</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>1770</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23031770</pub-id><pub-id pub-id-type="pmid">35163691</pub-id><pub-id pub-id-type="pmcid">PMC8836577</pub-id></element-citation></ref><ref id="B16-cimb-45-00324"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strzelak</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ratajczak</surname><given-names>A.</given-names></name><name name-style="western"><surname>Adamiec</surname><given-names>A.</given-names></name><name name-style="western"><surname>Feleszko</surname><given-names>W.</given-names></name></person-group><article-title>Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: A mechanistic review</article-title><source>Int. J. Environ. Res. Public Health</source><year>2018</year><volume>15</volume><elocation-id>1033</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph15051033</pub-id><pub-id pub-id-type="pmid">29883409</pub-id><pub-id pub-id-type="pmcid">PMC5982072</pub-id></element-citation></ref><ref id="B17-cimb-45-00324"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alsharairi</surname><given-names>N.A.</given-names></name></person-group><article-title>Scutellaria baicalensis and their natural flavone compounds as potential medicinal drugs for the treatment of nicotine-induced non-small-cell lung cancer and asthma</article-title><source>Int. J. Environ. Res. Public Health</source><year>2021</year><volume>18</volume><elocation-id>5243</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph18105243</pub-id><pub-id pub-id-type="pmid">34069141</pub-id><pub-id pub-id-type="pmcid">PMC8155851</pub-id></element-citation></ref><ref id="B18-cimb-45-00324"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vonk</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Scholtens</surname><given-names>S.</given-names></name><name name-style="western"><surname>Postma</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Moffatt</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Jarvis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ramasamy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wjst</surname><given-names>M.</given-names></name><name name-style="western"><surname>Omenaas</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Bouzigon</surname><given-names>E.</given-names></name><name name-style="western"><surname>Demenais</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Adult onset asthma and interaction between genes and active tobacco smoking: The GABRIEL consortium</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0172716</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0172716</pub-id><pub-id pub-id-type="pmid">28253294</pub-id><pub-id pub-id-type="pmcid">PMC5333809</pub-id></element-citation></ref><ref id="B19-cimb-45-00324"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uh</surname><given-names>S.-T.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.-S.</given-names></name><name name-style="western"><surname>Koo</surname><given-names>S.-M.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y.-K.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.U.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M.-A.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>S.-W.</given-names></name><name name-style="western"><surname>Son</surname><given-names>J.-H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.-W.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>H.D.</given-names></name><etal/></person-group><article-title>Association of genetic variants of NLRP4 with exacerbation of asthma: The effect of smoking</article-title><source>DNA Cell. Biol</source><year>2019</year><volume>38</volume><fpage>76</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1089/dna.2018.4433</pub-id><pub-id pub-id-type="pmid">30526007</pub-id></element-citation></ref><ref id="B20-cimb-45-00324"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Losol</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>J.-P.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y.-H.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>S.-J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>B.-S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.-S.</given-names></name></person-group><article-title>Genetic variants in the TLR-related pathway and smoking exposure alter the upper airway microbiota in adult asthmatic patients</article-title><source>Allergy</source><year>2021</year><volume>76</volume><fpage>3217</fpage><lpage>3220</lpage><pub-id pub-id-type="doi">10.1111/all.14970</pub-id><pub-id pub-id-type="pmid">34061362</pub-id></element-citation></ref><ref id="B21-cimb-45-00324"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>M.-H.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.-U.</given-names></name><name name-style="western"><surname>Shim</surname><given-names>J.-S.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.-S.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Park</surname><given-names>C.-S.</given-names></name></person-group><article-title>Association of genetic variants of oxidative stress responsive kinase 1 (<italic toggle="yes">OXSR1</italic>) with asthma exacerbations in non-smoking asthmatics</article-title><source>BMC Pulm. Med.</source><year>2022</year><volume>22</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/s12890-021-01741-x</pub-id><pub-id pub-id-type="pmid">34983467</pub-id><pub-id pub-id-type="pmcid">PMC8725257</pub-id></element-citation></ref><ref id="B22-cimb-45-00324"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belcaro</surname><given-names>G.</given-names></name><name name-style="western"><surname>Luzzi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cesinaro Di Rocco</surname><given-names>P.</given-names></name><name name-style="western"><surname>Cesarone</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Dugall</surname><given-names>M.</given-names></name><name name-style="western"><surname>Feragalli</surname><given-names>B.</given-names></name><name name-style="western"><surname>Errichi</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Ippolito</surname><given-names>E.</given-names></name><name name-style="western"><surname>Grossi</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Hosoi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Pycnogenol&#174; improvements in asthma management</article-title><source>Panminerva. Med.</source><year>2011</year><volume>53</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">22108478</pub-id></element-citation></ref><ref id="B23-cimb-45-00324"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Spears</surname><given-names>M.</given-names></name></person-group><article-title>The influence of smoking on the treatment response in patients with asthma</article-title><source>Curr. Opin. Allergy Clin. Immunol.</source><year>2005</year><volume>5</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1097/00130832-200502000-00011</pub-id><pub-id pub-id-type="pmid">15643345</pub-id></element-citation></ref><ref id="B24-cimb-45-00324"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Shepherd</surname><given-names>M.</given-names></name><name name-style="western"><surname>Spears</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>R.</given-names></name></person-group><article-title>Corticosteroid insensitivity in smokers with asthma: Clinicalevidence, mechanisms, and management</article-title><source>Treat Respir. Med.</source><year>2006</year><volume>5</volume><fpage>467</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.2165/00151829-200605060-00010</pub-id><pub-id pub-id-type="pmid">17154674</pub-id></element-citation></ref><ref id="B25-cimb-45-00324"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chatkin</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Dullius</surname><given-names>C.R.</given-names></name></person-group><article-title>The management of asthmatic smokers</article-title><source>Asthma Res. Pract.</source><year>2016</year><volume>2</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.1186/s40733-016-0025-7</pub-id><pub-id pub-id-type="pmid">27965778</pub-id><pub-id pub-id-type="pmcid">PMC5142412</pub-id></element-citation></ref><ref id="B26-cimb-45-00324"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duman</surname><given-names>B.</given-names></name><name name-style="western"><surname>Borekci</surname><given-names>S.</given-names></name><name name-style="western"><surname>Akdeniz</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gazioglu</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Deniz</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gemicioglu</surname><given-names>B.</given-names></name></person-group><article-title>Inhaled corticosteroids&#8217; effects on biomarkers in exhaled breath condensate and blood in patients newly diagnosed with asthma who smoke</article-title><source>J. Asthma</source><year>2022</year><volume>59</volume><fpage>1613</fpage><lpage>1620</lpage><pub-id pub-id-type="doi">10.1080/02770903.2021.1962341</pub-id><pub-id pub-id-type="pmid">34376110</pub-id></element-citation></ref><ref id="B27-cimb-45-00324"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alsharairi</surname><given-names>N.A.</given-names></name></person-group><article-title>The effects of dietary supplements on asthma and lung cancer risk in smokers and non-smokers: A review of the literature</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>725</elocation-id><pub-id pub-id-type="doi">10.3390/nu11040725</pub-id><pub-id pub-id-type="pmid">30925812</pub-id><pub-id pub-id-type="pmcid">PMC6521315</pub-id></element-citation></ref><ref id="B28-cimb-45-00324"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alsharairi</surname><given-names>N.A.</given-names></name></person-group><article-title>Supplements for smoking-related lung diseases</article-title><source>Encyclopedia</source><year>2021</year><volume>1</volume><fpage>76</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.3390/encyclopedia1010010</pub-id></element-citation></ref><ref id="B29-cimb-45-00324"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alsharairi</surname><given-names>N.A.</given-names></name></person-group><article-title>Dietary antioxidants and lung cancer risk in smokers and non-smokers</article-title><source>Healthcare</source><year>2022</year><volume>10</volume><elocation-id>2501</elocation-id><pub-id pub-id-type="doi">10.3390/healthcare10122501</pub-id><pub-id pub-id-type="pmid">36554027</pub-id><pub-id pub-id-type="pmcid">PMC9778085</pub-id></element-citation></ref><ref id="B30-cimb-45-00324"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santillan</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Camargo</surname><given-names>C.A.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Colditz</surname><given-names>G.A.</given-names></name></person-group><article-title>A meta-analysis of asthma and risk of lung cancer (United States)</article-title><source>Cancer Causes Control.</source><year>2003</year><volume>14</volume><fpage>327</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1023/A:1023982402137</pub-id><pub-id pub-id-type="pmid">12846363</pub-id></element-citation></ref><ref id="B31-cimb-45-00324"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenberger</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bickeb&#246;ller</surname><given-names>H.</given-names></name><name name-style="western"><surname>McCormack</surname><given-names>V.</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Duell</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Tj&#248;nneland</surname><given-names>A.</given-names></name><name name-style="western"><surname>Friis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Muscat</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wichmann</surname><given-names>H.E.</given-names></name><etal/></person-group><article-title>Asthma and lung cancer risk: A systematic investigation by the International Lung Cancer Consortium</article-title><source>Carcinogenesis</source><year>2012</year><volume>33</volume><fpage>587</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgr307</pub-id><pub-id pub-id-type="pmid">22198214</pub-id><pub-id pub-id-type="pmcid">PMC3291861</pub-id></element-citation></ref><ref id="B32-cimb-45-00324"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Dockery</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Neas</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Coull</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Raizenne</surname><given-names>M.</given-names></name><name name-style="western"><surname>Speizer</surname><given-names>F.E.</given-names></name></person-group><article-title>Low dietary nutrient intakes and respiratory health in adolescents</article-title><source>Chest</source><year>2007</year><volume>132</volume><fpage>238</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1378/chest.07-0038</pub-id><pub-id pub-id-type="pmid">17475634</pub-id></element-citation></ref><ref id="B33-cimb-45-00324"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Du</surname><given-names>J.</given-names></name></person-group><article-title>Association between dietary carotenoid intakes and the risk of asthma in adults: A cross-sectional study of NHANES, 2007&#8211;2012</article-title><source>BMJ Open</source><year>2022</year><volume>12</volume><fpage>e052320</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2021-052320</pub-id><pub-id pub-id-type="pmid">35701051</pub-id><pub-id pub-id-type="pmcid">PMC9198789</pub-id></element-citation></ref><ref id="B34-cimb-45-00324"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearson</surname><given-names>P.J.K.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Britton</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fogarty</surname><given-names>A.</given-names></name></person-group><article-title>Vitamin E supplements in asthma: A parallel group randomised placebo controlled trial</article-title><source>Thorax</source><year>2004</year><volume>59</volume><fpage>652</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1136/thx.2004.022616</pub-id><pub-id pub-id-type="pmid">15282383</pub-id><pub-id pub-id-type="pmcid">PMC1747112</pub-id></element-citation></ref><ref id="B35-cimb-45-00324"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shaheen</surname><given-names>S.O.</given-names></name><name name-style="western"><surname>Newson</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Rayman</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>A.P.-L.</given-names></name><name name-style="western"><surname>Tumilty</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Potts</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>White</surname><given-names>P.T.</given-names></name><name name-style="western"><surname>Burney</surname><given-names>P.G.J.</given-names></name></person-group><article-title>Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma</article-title><source>Thorax</source><year>2007</year><volume>62</volume><fpage>483</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1136/thx.2006.071563</pub-id><pub-id pub-id-type="pmid">17234657</pub-id><pub-id pub-id-type="pmcid">PMC2117223</pub-id></element-citation></ref><ref id="B36-cimb-45-00324"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van der Vaart</surname><given-names>H.</given-names></name><name name-style="western"><surname>Postma</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Timens</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ten Hacken</surname><given-names>N.H.T.</given-names></name></person-group><article-title>Acute effects of cigarette smoke on inflammation and oxidative stress: A review</article-title><source>Thorax</source><year>2004</year><volume>59</volume><fpage>713</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1136/thx.2003.012468</pub-id><pub-id pub-id-type="pmid">15282395</pub-id><pub-id pub-id-type="pmcid">PMC1747102</pub-id></element-citation></ref><ref id="B37-cimb-45-00324"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yadav</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Saini</surname><given-names>M.</given-names></name></person-group><article-title>Evaluation of systemic antioxidant level and oxidative stress in relation to lifestyle and disease progression in asthmatic patients</article-title><source>J. Med. Biochem.</source><year>2016</year><volume>35</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1515/jomb-2015-0006</pub-id><pub-id pub-id-type="pmid">28356865</pub-id><pub-id pub-id-type="pmcid">PMC5346802</pub-id></element-citation></ref><ref id="B38-cimb-45-00324"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bartoli</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Novelli</surname><given-names>F.</given-names></name><name name-style="western"><surname>Costa</surname><given-names>F.</given-names></name><name name-style="western"><surname>Malagrin&#242;</surname><given-names>L.</given-names></name><name name-style="western"><surname>Melosini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bacci</surname><given-names>E.</given-names></name><name name-style="western"><surname>Cianchetti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dente</surname><given-names>F.L.</given-names></name><name name-style="western"><surname>Di Franco</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vagaggini</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases</article-title><source>Mediators Inflamm.</source><year>2011</year><volume>2011</volume><fpage>891752</fpage><pub-id pub-id-type="doi">10.1155/2011/891752</pub-id><pub-id pub-id-type="pmid">21772668</pub-id><pub-id pub-id-type="pmcid">PMC3136125</pub-id></element-citation></ref><ref id="B39-cimb-45-00324"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anes</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Nasr</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Fetoui</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bchir</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chahdoura</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yacoub</surname><given-names>S.</given-names></name><name name-style="western"><surname>Garrouch</surname><given-names>A.</given-names></name><name name-style="western"><surname>Benzarti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tabka</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chahed</surname><given-names>K.</given-names></name></person-group><article-title>Alteration in systemic markers of oxidative and antioxidative status in Tunisian patients with asthma: Relationships with clinical severity and airflow limitation</article-title><source>J. Asthma</source><year>2016</year><volume>53</volume><fpage>227</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.3109/02770903.2015.1087559</pub-id><pub-id pub-id-type="pmid">26516659</pub-id></element-citation></ref><ref id="B40-cimb-45-00324"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mak</surname><given-names>J.C.W.</given-names></name><name name-style="western"><surname>Leung</surname><given-names>H.C.M.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Law</surname><given-names>B.K.W.</given-names></name><name name-style="western"><surname>Lam</surname><given-names>W.K.</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>K.W.T.</given-names></name><name name-style="western"><surname>Ip</surname><given-names>M.C.M.</given-names></name><name name-style="western"><surname>Chan-Yeung</surname><given-names>M.</given-names></name></person-group><article-title>Systemic oxidative and antioxidative status in Chinese patients with asthma</article-title><source>J. Allergy Clin. Immunol.</source><year>2004</year><volume>114</volume><fpage>260</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2004.05.013</pub-id><pub-id pub-id-type="pmid">15316500</pub-id></element-citation></ref><ref id="B41-cimb-45-00324"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nadeem</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chhabra</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Masood</surname><given-names>A.</given-names></name><name name-style="western"><surname>Raj</surname><given-names>H.G.</given-names></name></person-group><article-title>Increased oxidative stress and altered levels of antioxidants in asthma</article-title><source>J. Allergy Clin. Immunol.</source><year>2003</year><volume>111</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1067/mai.2003.17</pub-id><pub-id pub-id-type="pmid">12532099</pub-id></element-citation></ref><ref id="B42-cimb-45-00324"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deveci</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ilhan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Turgut</surname><given-names>T.</given-names></name><name name-style="western"><surname>Akpolat</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kirkil</surname><given-names>G.</given-names></name><name name-style="western"><surname>Muz</surname><given-names>M.H.</given-names></name></person-group><article-title>Glutathione and nitrite in induced sputum from patients with stable and acute asthma compared with controls</article-title><source>Ann. Allergy Asthma Immunol.</source><year>2004</year><volume>93</volume><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/S1081-1206(10)61452-4</pub-id><pub-id pub-id-type="pmid">15281477</pub-id></element-citation></ref><ref id="B43-cimb-45-00324"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hillas</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kostikas</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mantzouranis</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bessa</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kontogianni</surname><given-names>K.</given-names></name><name name-style="western"><surname>Papadaki</surname><given-names>G.</given-names></name><name name-style="western"><surname>Papiris</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alchanatis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Loukides</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bakakos</surname><given-names>P.</given-names></name></person-group><article-title>Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers</article-title><source>Respirology</source><year>2011</year><volume>16</volume><fpage>811</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1843.2011.01984.x</pub-id><pub-id pub-id-type="pmid">21545371</pub-id></element-citation></ref><ref id="B44-cimb-45-00324"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michils</surname><given-names>A.</given-names></name><name name-style="western"><surname>Louis</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pech&#233;</surname><given-names>R.</given-names></name><name name-style="western"><surname>Baldassarre</surname><given-names>S.</given-names></name><name name-style="western"><surname>Van Muylem</surname><given-names>A.</given-names></name></person-group><article-title>Exhaled nitric oxide as a marker of asthma control in smoking patients</article-title><source>Eur. Respir. J.</source><year>2009</year><volume>33</volume><fpage>1295</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1183/09031936.00154008</pub-id><pub-id pub-id-type="pmid">19164346</pub-id></element-citation></ref><ref id="B45-cimb-45-00324"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pavlidis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kwong</surname><given-names>F.N.K.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hoda</surname><given-names>U.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>K.</given-names></name><name name-style="western"><surname>Elyasigomari</surname><given-names>V.</given-names></name><name name-style="western"><surname>Agapow</surname><given-names>P.</given-names></name><name name-style="western"><surname>Loza</surname><given-names>M.</given-names></name><name name-style="western"><surname>Baribaud</surname><given-names>F.</given-names></name><etal/></person-group><article-title>&#8220;T2-high&#8221; in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin</article-title><source>Eur. Respir. J.</source><year>2019</year><volume>53</volume><fpage>1800938</fpage><pub-id pub-id-type="doi">10.1183/13993003.00938-2018</pub-id><pub-id pub-id-type="pmid">30578390</pub-id></element-citation></ref><ref id="B46-cimb-45-00324"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chamitava</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cazzoletti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ferrari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garcia-Larsen</surname><given-names>V.</given-names></name><name name-style="western"><surname>Jalil</surname><given-names>A.</given-names></name><name name-style="western"><surname>Degan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fois</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Zinellu</surname><given-names>E.</given-names></name><name name-style="western"><surname>Fois</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Pasini</surname><given-names>A.M.F.</given-names></name><etal/></person-group><article-title>Biomarkers of oxidative stress and inflammation in chronic airway diseases</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>4339</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21124339</pub-id><pub-id pub-id-type="pmid">32570774</pub-id><pub-id pub-id-type="pmcid">PMC7353047</pub-id></element-citation></ref><ref id="B47-cimb-45-00324"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malinovschi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Backer</surname><given-names>V.</given-names></name><name name-style="western"><surname>Harving</surname><given-names>H.</given-names></name><name name-style="western"><surname>Porsbjerg</surname><given-names>C.</given-names></name></person-group><article-title>The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms</article-title><source>Respir. Med.</source><year>2012</year><volume>106</volume><fpage>794</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2012.02.009</pub-id><pub-id pub-id-type="pmid">22405608</pub-id></element-citation></ref><ref id="B48-cimb-45-00324"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zietkowski</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Tomasiak-Lozowska</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Skiepko</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zietkowska</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bodzenta-Lukaszyk</surname><given-names>A.</given-names></name></person-group><article-title>Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients</article-title><source>Respir. Res.</source><year>2010</year><volume>11</volume><fpage>110</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-11-110</pub-id><pub-id pub-id-type="pmid">20704746</pub-id><pub-id pub-id-type="pmcid">PMC2929222</pub-id></element-citation></ref><ref id="B49-cimb-45-00324"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krisiukeniene</surname><given-names>A.</given-names></name><name name-style="western"><surname>Babusyte</surname><given-names>A.</given-names></name><name name-style="western"><surname>Stravinskaite</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lotvall</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sakalauskas</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sitkauskiene</surname><given-names>B.</given-names></name></person-group><article-title>Smoking affects eotaxin levels in asthma patients</article-title><source>J. Asthma</source><year>2009</year><volume>46</volume><fpage>470</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1080/02770900902846349</pub-id><pub-id pub-id-type="pmid">19544167</pub-id></element-citation></ref><ref id="B50-cimb-45-00324"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossios</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pavlidis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hoda</surname><given-names>U.</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>C.-H.</given-names></name><name name-style="western"><surname>Wiegman</surname><given-names>C.</given-names></name><name name-style="western"><surname>Russell</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>K.</given-names></name><name name-style="western"><surname>Loza</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Baribaud</surname><given-names>F.</given-names></name><name name-style="western"><surname>Durham</surname><given-names>A.L.</given-names></name><etal/></person-group><article-title>Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthma</article-title><source>J. Allergy Clin. Immunol.</source><year>2018</year><volume>141</volume><fpage>560</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2017.02.045</pub-id><pub-id pub-id-type="pmid">28528200</pub-id></element-citation></ref><ref id="B51-cimb-45-00324"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chalmers</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>MacLeod</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Little</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>McSharry</surname><given-names>C.</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>N.C.</given-names></name></person-group><article-title>Smoking and airway inflammation in patients with mild asthma</article-title><source>Chest</source><year>2001</year><volume>120</volume><fpage>1917</fpage><lpage>1922</lpage><pub-id pub-id-type="doi">10.1378/chest.120.6.1917</pub-id><pub-id pub-id-type="pmid">11742922</pub-id></element-citation></ref><ref id="B52-cimb-45-00324"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>R.</given-names></name><name name-style="western"><surname>Spears</surname><given-names>M.</given-names></name><name name-style="western"><surname>Haughney</surname><given-names>J.</given-names></name><name name-style="western"><surname>McSharry</surname><given-names>C.</given-names></name></person-group><article-title>Serum periostin in smokers and never smokers with asthma</article-title><source>Respir. Med.</source><year>2015</year><volume>109</volume><fpage>708</fpage><lpage>7015</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2015.03.009</pub-id><pub-id pub-id-type="pmid">25869478</pub-id></element-citation></ref><ref id="B53-cimb-45-00324"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yildiz</surname><given-names>H.</given-names></name><name name-style="western"><surname>Alp</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>S&#252;nnet&#231;io&#287;lu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ekin</surname><given-names>S.</given-names></name><name name-style="western"><surname>&#199;ilingir</surname><given-names>B.M.</given-names></name></person-group><article-title>Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma</article-title><source>Heart Lung</source><year>2021</year><volume>50</volume><fpage>177</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.hrtlng.2020.04.017</pub-id><pub-id pub-id-type="pmid">32475627</pub-id></element-citation></ref><ref id="B54-cimb-45-00324"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rovina</surname><given-names>N.</given-names></name><name name-style="western"><surname>Dima</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gerassimou</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kollintza</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gratziou</surname><given-names>C.</given-names></name><name name-style="western"><surname>Roussos</surname><given-names>C.</given-names></name></person-group><article-title>IL-18 in induced sputum and airway hyperresponsiveness in mild asthmatics: Effect of smoking</article-title><source>Respir. Med.</source><year>2009</year><volume>103</volume><fpage>1919</fpage><lpage>1925</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2009.05.023</pub-id><pub-id pub-id-type="pmid">19539457</pub-id></element-citation></ref><ref id="B55-cimb-45-00324"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ham</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>I.-W.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>B.-W.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>S.-H.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>J.-W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.Y.</given-names></name></person-group><article-title>Cigarette smoke aggravates asthma by inducing memory-like type 3 innate lymphoid cells</article-title><source>Nat. Commun.</source><year>2022</year><volume>13</volume><fpage>3852</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-31491-1</pub-id><pub-id pub-id-type="pmid">35789151</pub-id><pub-id pub-id-type="pmcid">PMC9253141</pub-id></element-citation></ref><ref id="B56-cimb-45-00324"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>L.</given-names></name></person-group><article-title>Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma</article-title><source>Respir. Med.</source><year>2015</year><volume>109</volume><fpage>1391</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2015.09.016</pub-id><pub-id pub-id-type="pmid">26459159</pub-id></element-citation></ref><ref id="B57-cimb-45-00324"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimoda</surname><given-names>T.</given-names></name><name name-style="western"><surname>Obase</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kishikawa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Iwanaga</surname><given-names>T.</given-names></name></person-group><article-title>Serum high-sensitivity C-reactive protein can be an airway inflammation predictor in bronchial asthma</article-title><source>Allergy Asthma Proc.</source><year>2015</year><volume>36</volume><fpage>e23</fpage><lpage>e28</lpage><pub-id pub-id-type="doi">10.2500/aap.2015.36.3816</pub-id><pub-id pub-id-type="pmid">25715235</pub-id></element-citation></ref><ref id="B58-cimb-45-00324"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halvani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tahghighi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Nadooshan</surname><given-names>H.H.</given-names></name></person-group><article-title>Evaluation of correlation between airway and serum inflammatory markers in asthmatic patients</article-title><source>Lung. India</source><year>2012</year><volume>29</volume><fpage>143</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.4103/0970-2113.95317</pub-id><pub-id pub-id-type="pmid">22628929</pub-id><pub-id pub-id-type="pmcid">PMC3354488</pub-id></element-citation></ref><ref id="B59-cimb-45-00324"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mikus</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Kolmert</surname><given-names>J.</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>L.I.</given-names></name><name name-style="western"><surname>&#214;stling</surname><given-names>J.</given-names></name><name name-style="western"><surname>Knowles</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>G&#243;mez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ericsson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Th&#246;rngren</surname><given-names>J.-O.</given-names></name><name name-style="western"><surname>Khoonsari</surname><given-names>P.E.</given-names></name><name name-style="western"><surname>Dahl&#233;n</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation</article-title><source>Eur. Respir. J.</source><year>2022</year><volume>59</volume><fpage>2100142</fpage><pub-id pub-id-type="doi">10.1183/13993003.00142-2021</pub-id><pub-id pub-id-type="pmid">34737220</pub-id><pub-id pub-id-type="pmcid">PMC8850689</pub-id></element-citation></ref><ref id="B60-cimb-45-00324"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pavlidis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kwong</surname><given-names>F.N.K.</given-names></name><name name-style="western"><surname>Hoda</surname><given-names>U.</given-names></name><name name-style="western"><surname>Rossios</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>K.</given-names></name><name name-style="western"><surname>Loza</surname><given-names>M.</given-names></name><name name-style="western"><surname>Baribaud</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chanez</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>S.J.</given-names></name><etal/></person-group><article-title>Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: An exploratory analysis</article-title><source>Eur. Respir. J.</source><year>2018</year><volume>51</volume><fpage>1702173</fpage><pub-id pub-id-type="doi">10.1183/13993003.02173-2017</pub-id><pub-id pub-id-type="pmid">29650557</pub-id></element-citation></ref><ref id="B61-cimb-45-00324"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emma</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bansal</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Kolmert</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wheelock</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Dahlen</surname><given-names>S.-E.</given-names></name><name name-style="western"><surname>Loza</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>De Meulder</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lefaudeux</surname><given-names>D.</given-names></name><name name-style="western"><surname>Auffray</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dahlen</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0203874</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0203874</pub-id><pub-id pub-id-type="pmid">30240401</pub-id><pub-id pub-id-type="pmcid">PMC6150501</pub-id></element-citation></ref><ref id="B62-cimb-45-00324"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>R.</given-names></name><name name-style="western"><surname>Heaney</surname><given-names>L.G.</given-names></name><name name-style="western"><surname>Bucknall</surname><given-names>C.</given-names></name><name name-style="western"><surname>Niven</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Brightling</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Menzies-Gow</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Mansur</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>McSharry</surname><given-names>C.</given-names></name></person-group><article-title>Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma</article-title><source>J. Allergy Clin. Immunol.</source><year>2013</year><volume>131</volume><fpage>1008</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2012.12.1574</pub-id><pub-id pub-id-type="pmid">23419540</pub-id></element-citation></ref><ref id="B63-cimb-45-00324"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giovannelli</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ch&#233;rot-Kornobis</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hulo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ciuchete</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cl&#233;ment</surname><given-names>G.</given-names></name><name name-style="western"><surname>Amouyel</surname><given-names>P.</given-names></name><name name-style="western"><surname>Matran</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dauchet</surname><given-names>L.</given-names></name></person-group><article-title>Both exhaled nitric oxide and blood eosinophil count were associated with mild allergic asthma only in non-smokers</article-title><source>Clin. Exp. Allergy</source><year>2016</year><volume>46</volume><fpage>543</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1111/cea.12669</pub-id><pub-id pub-id-type="pmid">26542195</pub-id></element-citation></ref><ref id="B64-cimb-45-00324"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kostikas</surname><given-names>K.</given-names></name><name name-style="western"><surname>Papaioannou</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>Tanou</surname><given-names>K.</given-names></name><name name-style="western"><surname>Giouleka</surname><given-names>P.</given-names></name><name name-style="western"><surname>Koutsokera</surname><given-names>A.</given-names></name><name name-style="western"><surname>Minas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Papiris</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gourgoulianis</surname><given-names>K.I.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Loukides</surname><given-names>S.</given-names></name></person-group><article-title>Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control</article-title><source>Respir. Med.</source><year>2011</year><volume>105</volume><fpage>e526</fpage><lpage>e532</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2010.10.015</pub-id><pub-id pub-id-type="pmid">21051211</pub-id></element-citation></ref><ref id="B65-cimb-45-00324"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mai</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Smoking status modifies the relationship between Th2 biomarkers and small airway obstruction in asthma</article-title><source>Can. Respir. J.</source><year>2021</year><volume>2021</volume><fpage>1918518</fpage><pub-id pub-id-type="doi">10.1155/2021/1918518</pub-id><pub-id pub-id-type="pmid">34876944</pub-id><pub-id pub-id-type="pmcid">PMC8645388</pub-id></element-citation></ref><ref id="B66-cimb-45-00324"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nerpin</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Weyler</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schlunnsen</surname><given-names>V.</given-names></name><name name-style="western"><surname>Jogi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Semjen</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Gislasson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Demoly</surname><given-names>P.</given-names></name><name name-style="western"><surname>Heinrich</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nowak</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Bronchodilator response and lung function decline: Associations with exhaled nitric oxide with regard to sex and smoking status</article-title><source>World Allergy Organ. J.</source><year>2021</year><volume>14</volume><fpage>100544</fpage><pub-id pub-id-type="doi">10.1016/j.waojou.2021.100544</pub-id><pub-id pub-id-type="pmid">34093956</pub-id><pub-id pub-id-type="pmcid">PMC8142084</pub-id></element-citation></ref><ref id="B67-cimb-45-00324"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cianchetti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cardini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Puxeddu</surname><given-names>I.</given-names></name><name name-style="western"><surname>Latorre</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bartoli</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Bradicich</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dente</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bacci</surname><given-names>E.</given-names></name><name name-style="western"><surname>Celi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paggiaro</surname><given-names>P.</given-names></name></person-group><article-title>Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction</article-title><source>World Allergy Organ. J.</source><year>2019</year><volume>12</volume><fpage>100078</fpage><pub-id pub-id-type="doi">10.1016/j.waojou.2019.100078</pub-id><pub-id pub-id-type="pmid">31871533</pub-id><pub-id pub-id-type="pmcid">PMC6911957</pub-id></element-citation></ref><ref id="B68-cimb-45-00324"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Timoneda</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Fern&#225;ndez</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zaragoz&#225;</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Cabezuelo</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Torres</surname><given-names>L.</given-names></name><name name-style="western"><surname>Vi&#241;a</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Barber</surname><given-names>T.</given-names></name></person-group><article-title>Vitamin A deficiency and the lung</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>1132</elocation-id><pub-id pub-id-type="doi">10.3390/nu10091132</pub-id><pub-id pub-id-type="pmid">30134568</pub-id><pub-id pub-id-type="pmcid">PMC6164133</pub-id></element-citation></ref><ref id="B69-cimb-45-00324"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Defnet</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>P.</given-names></name><name name-style="western"><surname>Deshpande</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Kane</surname><given-names>M.A.</given-names></name></person-group><article-title>Dysregulated retinoic acid signaling in airway smooth muscle cells in asthma</article-title><source>FASEB J.</source><year>2021</year><volume>35</volume><fpage>e22016</fpage><pub-id pub-id-type="doi">10.1096/fj.202100835R</pub-id><pub-id pub-id-type="pmid">34784434</pub-id><pub-id pub-id-type="pmcid">PMC9361782</pub-id></element-citation></ref><ref id="B70-cimb-45-00324"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Druilhe</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zahm</surname><given-names>J.-M.</given-names></name><name name-style="western"><surname>Benayoun</surname><given-names>L.</given-names></name><name name-style="western"><surname>El Mehdi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Grandsaigne</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dombret</surname><given-names>M.-C.</given-names></name><name name-style="western"><surname>Mosnier</surname><given-names>I.</given-names></name><name name-style="western"><surname>Feger</surname><given-names>B.</given-names></name><name name-style="western"><surname>Depondt</surname><given-names>J.</given-names></name><name name-style="western"><surname>Aubier</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Epithelium expression and function of retinoid receptors in asthma</article-title><source>Am. J. Respir. Cell. Mol. Biol.</source><year>2008</year><volume>38</volume><fpage>276</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2006-0453OC</pub-id><pub-id pub-id-type="pmid">17884991</pub-id></element-citation></ref><ref id="B71-cimb-45-00324"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Day</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y.J.</given-names></name></person-group><article-title>Retinoic acid inhibits airway smooth muscle cell migration</article-title><source>Am. J. Respir. Cell. Mol. Biol.</source><year>2006</year><volume>34</volume><fpage>695</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2005-0306OC</pub-id><pub-id pub-id-type="pmid">16456186</pub-id><pub-id pub-id-type="pmcid">PMC1831536</pub-id></element-citation></ref><ref id="B72-cimb-45-00324"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Callaghan</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Rybakovsky</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ferrick</surname><given-names>B.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mullin</surname><given-names>J.M.</given-names></name></person-group><article-title>Retinoic acid improves baseline barrier function and attenuates TNF-&#945;-induced barrier leak in human bronchial epithelial cell culture model, 16HBE 14o</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><elocation-id>e0242536</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0242536</pub-id><pub-id pub-id-type="pmid">33301441</pub-id><pub-id pub-id-type="pmcid">PMC7728186</pub-id></element-citation></ref><ref id="B73-cimb-45-00324"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Z.</given-names></name></person-group><article-title>All-trans retinoic acid attenuates airway inflammation by inhibiting Th2 and Th17 response in experimental allergic asthma</article-title><source>BMC Immunol.</source><year>2013</year><volume>14</volume><elocation-id>28</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2172-14-28</pub-id><pub-id pub-id-type="pmid">23800145</pub-id><pub-id pub-id-type="pmcid">PMC3695807</pub-id></element-citation></ref><ref id="B74-cimb-45-00324"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takamura</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nasuhara</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Betsuyaku</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tanino</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kinoshita</surname><given-names>I.</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Matsukura</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schleimer</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>M.</given-names></name></person-group><article-title>Retinoic acid inhibits interleukin-4-induced eotaxin production in a human bronchial epithelial cell line</article-title><source>Am. J. Physiol. Lung. Cell. Mol. Physiol.</source><year>2004</year><volume>286</volume><fpage>L777</fpage><lpage>L785</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00289.2003</pub-id><pub-id pub-id-type="pmid">14660485</pub-id></element-citation></ref><ref id="B75-cimb-45-00324"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurie</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Lotan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Morice</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X.-C.</given-names></name><name name-style="western"><surname>Khuri</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Ro</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Hittelman</surname><given-names>W.N.</given-names></name><etal/></person-group><article-title>Treatment of former smokers with 9-<italic toggle="yes">cis</italic>-retinoic acid reverses loss of retinoic acid receptorbeta expression in the bronchial epithelium: Results from a randomized placebo-controlled trial</article-title><source>J. Natl. Cancer. Inst.</source><year>2003</year><volume>95</volume><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1093/jnci/95.3.206</pub-id><pub-id pub-id-type="pmid">12569142</pub-id></element-citation></ref><ref id="B76-cimb-45-00324"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frankenberger</surname><given-names>M.</given-names></name><name name-style="western"><surname>Heimbeck</surname><given-names>I.</given-names></name><name name-style="western"><surname>M&#246;ller</surname><given-names>W.</given-names></name><name name-style="western"><surname>Mamidi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ka&#223;ner</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pukelsheim</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wjst</surname><given-names>M.</given-names></name><name name-style="western"><surname>Neiswirth</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kroneberg</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lomas</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Inhaled all-trans retinoic acid in an individual with severe emphysema</article-title><source>Eur. Respir. J.</source><year>2009</year><volume>34</volume><fpage>1487</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.1183/09031936.00105309</pub-id><pub-id pub-id-type="pmid">19948915</pub-id></element-citation></ref><ref id="B77-cimb-45-00324"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saini</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lokesh</surname><given-names>V.</given-names></name><name name-style="western"><surname>Shang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Keum</surname><given-names>Y.-S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.-H.</given-names></name></person-group><article-title>Carotenoids: Dietary sources, extraction, encapsulation, bioavailability, and health benefits-A review of recent advancements</article-title><source>Antioxidants</source><year>2022</year><volume>11</volume><elocation-id>795</elocation-id><pub-id pub-id-type="doi">10.3390/antiox11040795</pub-id><pub-id pub-id-type="pmid">35453480</pub-id><pub-id pub-id-type="pmcid">PMC9025559</pub-id></element-citation></ref><ref id="B78-cimb-45-00324"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.O.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.C.</given-names></name></person-group><article-title>The roles of phytochemicals in bronchial asthma</article-title><source>Molecules</source><year>2010</year><volume>15</volume><fpage>6810</fpage><lpage>6834</lpage><pub-id pub-id-type="doi">10.3390/molecules15106810</pub-id><pub-id pub-id-type="pmid">20924320</pub-id><pub-id pub-id-type="pmcid">PMC6259268</pub-id></element-citation></ref><ref id="B79-cimb-45-00324"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arora</surname><given-names>A.</given-names></name><name name-style="western"><surname>Willhite</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Liebler</surname><given-names>D.C.</given-names></name></person-group><article-title>Interactions of beta-carotene and cigarette smoke in human bronchial epithelial cells</article-title><source>Carcinogenesis</source><year>2001</year><volume>22</volume><fpage>1173</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1093/carcin/22.8.1173</pub-id><pub-id pub-id-type="pmid">11470745</pub-id></element-citation></ref><ref id="B80-cimb-45-00324"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prakash</surname><given-names>P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>K.-Q.</given-names></name><name name-style="western"><surname>Krinsky</surname><given-names>N.I.</given-names></name><name name-style="western"><surname>Russell</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.-D.</given-names></name></person-group><article-title>Beta-carotene and beta-apo-14&#8242;-carotenoic acid prevent the reduction of retinoic acid receptor beta in benzo[a]pyrene-treated normal human bronchial epithelial cells</article-title><source>J. Nutr.</source><year>2004</year><volume>134</volume><fpage>667</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1093/jn/134.3.667</pub-id><pub-id pub-id-type="pmid">14988465</pub-id></element-citation></ref><ref id="B81-cimb-45-00324"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hazlewood</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Wood</surname><given-names>L.G.</given-names></name><name name-style="western"><surname>Hansbro</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>P.S.</given-names></name></person-group><article-title>Dietary lycopene supplementation suppresses Th2 responses and lung eosinophilia in a mouse model of allergic asthma</article-title><source>J. Nutr. Biochem.</source><year>2011</year><volume>22</volume><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2009.12.003</pub-id><pub-id pub-id-type="pmid">20392623</pub-id></element-citation></ref><ref id="B82-cimb-45-00324"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lian</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.-D.</given-names></name></person-group><article-title>Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells</article-title><source>Int. J. Cancer</source><year>2008</year><volume>123</volume><fpage>1262</fpage><lpage>1268</lpage><pub-id pub-id-type="doi">10.1002/ijc.23696</pub-id><pub-id pub-id-type="pmid">18566994</pub-id><pub-id pub-id-type="pmcid">PMC3057886</pub-id></element-citation></ref><ref id="B83-cimb-45-00324"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiaverelli</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>K.-Q.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mein</surname><given-names>J.</given-names></name><name name-style="western"><surname>von Lintig</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.-D.</given-names></name></person-group><article-title>&#946;-Cryptoxanthin attenuates cigarette-smoke-induced lung lesions in the absence of carotenoid cleavage enzymes (BCO1/BCO2) in mice</article-title><source>Molecules</source><year>2023</year><volume>28</volume><elocation-id>1383</elocation-id><pub-id pub-id-type="doi">10.3390/molecules28031383</pub-id><pub-id pub-id-type="pmid">36771049</pub-id><pub-id pub-id-type="pmcid">PMC9920649</pub-id></element-citation></ref><ref id="B84-cimb-45-00324"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bronson</surname><given-names>R.T.</given-names></name><name name-style="western"><surname>Russell</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.-D.</given-names></name></person-group><article-title>&#946;-Cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage, and squamous metaplasia in ferrets</article-title><source>Cancer Prev. Res.</source><year>2011</year><volume>4</volume><fpage>1255</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-10-0384</pub-id><pub-id pub-id-type="pmcid">PMC3151338</pub-id><pub-id pub-id-type="pmid">21421799</pub-id></element-citation></ref><ref id="B85-cimb-45-00324"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Britton</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Leonardi-Bee</surname><given-names>J.A.</given-names></name></person-group><article-title>Association between antioxidant vitamins and asthma outcome measures: Systematic review and meta-analysis</article-title><source>Thorax</source><year>2009</year><volume>64</volume><fpage>610</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1136/thx.2008.101469</pub-id><pub-id pub-id-type="pmid">19406861</pub-id></element-citation></ref><ref id="B86-cimb-45-00324"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tecklenburg</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Mickleborough</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Fly</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Stager</surname><given-names>J.M.</given-names></name></person-group><article-title>Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma</article-title><source>Respir. Med.</source><year>2007</year><volume>101</volume><fpage>1770</fpage><lpage>1778</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2007.02.014</pub-id><pub-id pub-id-type="pmid">17412579</pub-id></element-citation></ref><ref id="B87-cimb-45-00324"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>H.-H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.-S.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J.-Y.</given-names></name></person-group><article-title>High dose vitamin C supplementation increases the Th1/Th2 cytokine secretion ratio, but decreases eosinophilic infiltration in bronchoalveolar lavage fluid of ovalbumin-sensitized and challenged mice</article-title><source>J. Agric. Food Chem.</source><year>2009</year><volume>57</volume><fpage>10471</fpage><lpage>10476</lpage><pub-id pub-id-type="doi">10.1021/jf902403p</pub-id><pub-id pub-id-type="pmid">19831405</pub-id></element-citation></ref><ref id="B88-cimb-45-00324"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Cromie</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>T.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W.</given-names></name></person-group><article-title>Curcumin and vitamin E protect against adverse effects of benzo[a]pyrene in lung epithelial cells</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e92992</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0092992</pub-id><pub-id pub-id-type="pmid">24664296</pub-id><pub-id pub-id-type="pmcid">PMC3963982</pub-id></element-citation></ref><ref id="B89-cimb-45-00324"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoskins</surname><given-names>A.</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Milne</surname><given-names>G.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Dworski</surname><given-names>R.</given-names></name></person-group><article-title>Natural-source d-&#945;-tocopheryl acetate inhibits oxidant stress and modulates atopic asthma in humans In Vivo</article-title><source>Allergy</source><year>2012</year><volume>67</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1111/j.1398-9995.2012.02810.x</pub-id><pub-id pub-id-type="pmid">22435735</pub-id><pub-id pub-id-type="pmcid">PMC3476459</pub-id></element-citation></ref><ref id="B90-cimb-45-00324"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiser</surname><given-names>J.</given-names></name><name name-style="western"><surname>Alexis</surname><given-names>N.E.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Robinette</surname><given-names>C.</given-names></name><name name-style="western"><surname>Roubey</surname><given-names>R.</given-names></name><name name-style="western"><surname>Peden</surname><given-names>D.B.</given-names></name></person-group><article-title>In vivo gamma-tocopherol supplementation decreases systemic oxidative stress and cytokine responses of human monocytes in normal and asthmatic subjects</article-title><source>Free Radic. Biol. Med.</source><year>2008</year><volume>45</volume><fpage>40</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.03.002</pub-id><pub-id pub-id-type="pmid">18405673</pub-id><pub-id pub-id-type="pmcid">PMC2492672</pub-id></element-citation></ref><ref id="B91-cimb-45-00324"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hernandez</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Kala</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mills</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wells</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Alexis</surname><given-names>N.E.</given-names></name><name name-style="western"><surname>Lay</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Vitamin E, &#947;-tocopherol, reduces airway neutrophil recruitment after inhaled endotoxin challenge in rats and in healthy volunteers</article-title><source>Free Radic. Biol. Med.</source><year>2013</year><volume>60</volume><fpage>56</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.02.001</pub-id><pub-id pub-id-type="pmid">23402870</pub-id><pub-id pub-id-type="pmcid">PMC3654053</pub-id></element-citation></ref><ref id="B92-cimb-45-00324"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burbank</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Duran</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wells</surname><given-names>H.</given-names></name><name name-style="western"><surname>Alexis</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Gamma tocopherol-enriched supplement reduces sputum eosinophilia and endotoxin-induced sputum neutrophilia in volunteers with asthma</article-title><source>J. Allergy Clin. Immunol.</source><year>2018</year><volume>141</volume><fpage>1231</fpage><lpage>1238.e1</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2017.06.029</pub-id><pub-id pub-id-type="pmid">28736267</pub-id><pub-id pub-id-type="pmcid">PMC5775926</pub-id></element-citation></ref><ref id="B93-cimb-45-00324"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Talati</surname><given-names>M.</given-names></name><name name-style="western"><surname>Meyrick</surname><given-names>B.</given-names></name><name name-style="western"><surname>Peebles Jr</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Dworski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mernaugh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>D.</given-names></name><name name-style="western"><surname>Boothby</surname><given-names>M.</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Sheller</surname><given-names>J.R.</given-names></name></person-group><article-title>Oxidant stress modulates murine allergic airway responses</article-title><source>Free Radic. Biol. Med.</source><year>2006</year><volume>40</volume><fpage>1210</fpage><lpage>1219</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2005.11.012</pub-id><pub-id pub-id-type="pmid">16545689</pub-id></element-citation></ref><ref id="B94-cimb-45-00324"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quoc</surname><given-names>Q.L.</given-names></name><name name-style="western"><surname>Bich</surname><given-names>T.C.T.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.-H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.-S.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>Y.S.</given-names></name></person-group><article-title>Administration of vitamin E attenuates airway inflammation through restoration of Nrf2 in a mouse model of asthma</article-title><source>J. Cell Mol. Med.</source><year>2021</year><volume>25</volume><fpage>6721</fpage><lpage>6732</lpage><pub-id pub-id-type="doi">10.1111/jcmm.16675</pub-id><pub-id pub-id-type="pmid">34089243</pub-id><pub-id pub-id-type="pmcid">PMC8278095</pub-id></element-citation></ref><ref id="B95-cimb-45-00324"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kwan</surname><given-names>J.K.C.</given-names></name><name name-style="western"><surname>Yeung</surname><given-names>K.L.</given-names></name><etal/></person-group><article-title>Application of vitamin E to antagonize SWCNTs-induced exacerbation of allergic asthma</article-title><source>Sci. Rep.</source><year>2014</year><volume>4</volume><fpage>4275</fpage><pub-id pub-id-type="doi">10.1038/srep04275</pub-id><pub-id pub-id-type="pmid">24589727</pub-id><pub-id pub-id-type="pmcid">PMC3940970</pub-id></element-citation></ref><ref id="B96-cimb-45-00324"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mabalirajan</surname><given-names>U.</given-names></name><name name-style="western"><surname>Aich</surname><given-names>J.</given-names></name><name name-style="western"><surname>Leishangthem</surname><given-names>G.D.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Dinda</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>B.</given-names></name></person-group><article-title>Effects of vitamin E on mitochondrial dysfunction and asthma features in an experimental allergic murine model</article-title><source>J. Appl. Physiol.</source><year>2009</year><volume>107</volume><fpage>1285</fpage><lpage>1292</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00459.2009</pub-id><pub-id pub-id-type="pmid">19628725</pub-id><pub-id pub-id-type="pmcid">PMC2763843</pub-id></element-citation></ref><ref id="B97-cimb-45-00324"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCary</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Abdala-Valencia</surname><given-names>H.</given-names></name><name name-style="western"><surname>Berdnikovs</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cook-Mills</surname><given-names>J.M.</given-names></name></person-group><article-title>Supplemental and highly elevated tocopherol doses differentially regulate allergic inflammation: Reversibility of &#945;-tocopherol and &#947;-tocopherol&#8217;s effects</article-title><source>J. Immunol.</source><year>2011</year><volume>186</volume><fpage>3674</fpage><lpage>3685</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1003037</pub-id><pub-id pub-id-type="pmid">21317387</pub-id><pub-id pub-id-type="pmcid">PMC3271805</pub-id></element-citation></ref><ref id="B98-cimb-45-00324"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>D.K.</given-names></name></person-group><article-title>Vitamin D and bronchial asthma: An overview of data from the past 5 years</article-title><source>Clin. Ther.</source><year>2017</year><volume>39</volume><fpage>917</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2017.04.002</pub-id><pub-id pub-id-type="pmid">28449868</pub-id><pub-id pub-id-type="pmcid">PMC5607643</pub-id></element-citation></ref><ref id="B99-cimb-45-00324"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfeffer</surname><given-names>P.E.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mann</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.-H.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>T.-R.</given-names></name><name name-style="western"><surname>Cousins</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Corrigan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Mudway</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Hawrylowicz</surname><given-names>C.M.</given-names></name></person-group><article-title>Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matter</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0200040</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0200040</pub-id><pub-id pub-id-type="pmid">30157189</pub-id><pub-id pub-id-type="pmcid">PMC6114286</pub-id></element-citation></ref><ref id="B100-cimb-45-00324"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramos-Mart&#237;nez</surname><given-names>E.</given-names></name><name name-style="western"><surname>L&#243;pez-Vancell</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Fern&#225;ndez de C&#243;rdova-Aguirre</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Rojas-Serrano</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chavarr&#237;a</surname><given-names>A.</given-names></name><name name-style="western"><surname>Velasco-Medina</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vel&#225;zquez-S&#225;mano</surname><given-names>G.</given-names></name></person-group><article-title>Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFN&#947; levels and cathelicidin expression</article-title><source>Cytokine</source><year>2018</year><volume>108</volume><fpage>239</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2018.01.001</pub-id><pub-id pub-id-type="pmid">29402723</pub-id></element-citation></ref><ref id="B101-cimb-45-00324"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adam-Bonci</surname><given-names>T.-I.</given-names></name><name name-style="western"><surname>Bonci</surname><given-names>E.-A.</given-names></name><name name-style="western"><surname>P&#226;rvu</surname><given-names>A.-E.</given-names></name><name name-style="western"><surname>Herdean</surname><given-names>A.-I.</given-names></name><name name-style="western"><surname>Mo&#539;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Taulescu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ungur</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pop</surname><given-names>R.-M.</given-names></name><name name-style="western"><surname>Boc&#537;an</surname><given-names>C.</given-names></name><name name-style="western"><surname>Irimie</surname><given-names>A.</given-names></name></person-group><article-title>Vitamin D supplementation: Oxidative stress modulation in a mouse model of ovalbumin-induced acute asthmatic airway inflammation</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>7089</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22137089</pub-id><pub-id pub-id-type="pmid">34209324</pub-id><pub-id pub-id-type="pmcid">PMC8268667</pub-id></element-citation></ref><ref id="B102-cimb-45-00324"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xian</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name></person-group><article-title>Vitamin D ameliorates asthma-induced lung injury by regulating HIF-1&#945;/Notch1 signaling during autophagy</article-title><source>Food Sci. Nutr.</source><year>2022</year><volume>10</volume><fpage>2773</fpage><lpage>2785</lpage><pub-id pub-id-type="doi">10.1002/fsn3.2880</pub-id><pub-id pub-id-type="pmid">35959262</pub-id><pub-id pub-id-type="pmcid">PMC9361460</pub-id></element-citation></ref><ref id="B103-cimb-45-00324"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>D.K.</given-names></name></person-group><article-title>Vitamin D supplementation reduces induction of epithelial-mesenchymal transition in allergen sensitized and challenged mice</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0149180</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0149180</pub-id><pub-id pub-id-type="pmid">26872336</pub-id><pub-id pub-id-type="pmcid">PMC4752470</pub-id></element-citation></ref><ref id="B104-cimb-45-00324"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Weeden</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>D.H.W.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Hart</surname><given-names>J.</given-names></name><name name-style="western"><surname>Foong</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Mok</surname><given-names>D.</given-names></name><name name-style="western"><surname>Stephens</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zosky</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hart</surname><given-names>P.H.</given-names></name></person-group><article-title>Reversible control by vitamin D of granulocytes and bacteria in the lungs of mice: An ovalbumin-induced model of allergic airway disease</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e67823</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0067823</pub-id><pub-id pub-id-type="pmid">23826346</pub-id><pub-id pub-id-type="pmcid">PMC3691156</pub-id></element-citation></ref><ref id="B105-cimb-45-00324"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taher</surname><given-names>Y.A.</given-names></name><name name-style="western"><surname>van Esch</surname><given-names>B.C.A.M.</given-names></name><name name-style="western"><surname>Hofman</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Henricks</surname><given-names>P.A.J.</given-names></name><name name-style="western"><surname>van Oosterhout</surname><given-names>A.J.M.</given-names></name></person-group><article-title>1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: Role for IL-10 and TGF-beta</article-title><source>J. Immunol.</source><year>2008</year><volume>180</volume><fpage>5211</fpage><lpage>5221</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.8.5211</pub-id><pub-id pub-id-type="pmid">18390702</pub-id></element-citation></ref><ref id="B106-cimb-45-00324"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agrawal</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>G.K.</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>D.K.</given-names></name></person-group><article-title>Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model</article-title><source>Clin. Exp. Allergy</source><year>2013</year><volume>43</volume><fpage>672</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">23711130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cea.12102</pub-id><pub-id pub-id-type="pmcid">PMC3671499</pub-id></element-citation></ref><ref id="B107-cimb-45-00324"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>B.</given-names></name><name name-style="western"><surname>Shang</surname><given-names>Y.</given-names></name></person-group><article-title>Vitamin D reduces inflammatory response in asthmatic mice through HMGB1/TLR4/NF-&#954;B signaling pathway</article-title><source>Mol. Med. Rep.</source><year>2018</year><volume>17</volume><fpage>2915</fpage><lpage>2920</lpage><pub-id pub-id-type="pmid">29257249</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/mmr.2017.8216</pub-id><pub-id pub-id-type="pmcid">PMC5783507</pub-id></element-citation></ref><ref id="B108-cimb-45-00324"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ekmekci</surname><given-names>O.P.</given-names></name><name name-style="western"><surname>Donma</surname><given-names>O.</given-names></name><name name-style="western"><surname>Sardo&#287;an</surname><given-names>E.</given-names></name><name name-style="western"><surname>Yildirim</surname><given-names>N.</given-names></name><name name-style="western"><surname>Uysal</surname><given-names>O.</given-names></name><name name-style="western"><surname>Demirel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Demir</surname><given-names>T.</given-names></name></person-group><article-title>Iron, nitric oxide, and myeloperoxidase in asthmatic patients</article-title><source>Biochemistry</source><year>2004</year><volume>69</volume><fpage>462</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1023/B:BIRY.0000026205.89894.25</pub-id><pub-id pub-id-type="pmid">15170385</pub-id></element-citation></ref><ref id="B109-cimb-45-00324"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Narula</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Ahuja</surname><given-names>G.K.</given-names></name><name name-style="western"><surname>Whig</surname><given-names>J.</given-names></name><name name-style="western"><surname>Narang</surname><given-names>A.P.S.</given-names></name><name name-style="western"><surname>Soni</surname><given-names>R.K.</given-names></name></person-group><article-title>Status of lipid peroxidation and plasma iron level in bronchial asthmatic patients</article-title><source>Indian J. Physiol. Pharmacol.</source><year>2007</year><volume>51</volume><fpage>289</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">18341227</pub-id></element-citation></ref><ref id="B110-cimb-45-00324"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>Z.</given-names></name></person-group><article-title>Interleukin-6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species-dependent lipid peroxidation and disrupting iron homeostasis</article-title><source>Bioengineered</source><year>2021</year><volume>12</volume><fpage>5279</fpage><lpage>5288</lpage><pub-id pub-id-type="doi">10.1080/21655979.2021.1964158</pub-id><pub-id pub-id-type="pmid">34402724</pub-id><pub-id pub-id-type="pmcid">PMC8806540</pub-id></element-citation></ref><ref id="B111-cimb-45-00324"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuribayashi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Iida</surname><given-names>S.-I.</given-names></name><name name-style="western"><surname>Nakajima</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Funaguchi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Tabata</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fukuoka</surname><given-names>K.</given-names></name><name name-style="western"><surname>Fujimori</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ihaku</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>T.</given-names></name></person-group><article-title>Suppression of heme oxygenase-1 activity reduces airway hyperresponsiveness and inflammation in a mouse model of asthma</article-title><source>J. Asthma</source><year>2015</year><volume>52</volume><fpage>662</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.3109/02770903.2015.1008138</pub-id><pub-id pub-id-type="pmid">26133060</pub-id></element-citation></ref><ref id="B112-cimb-45-00324"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghio</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Hilborn</surname><given-names>E.D.</given-names></name></person-group><article-title>Indices of iron homeostasis correlate with airway obstruction in an NHANES III cohort</article-title><source>Int. J. Chron. Obstruct. Pulmon. Dis.</source><year>2017</year><volume>12</volume><fpage>2075</fpage><lpage>2084</lpage><pub-id pub-id-type="doi">10.2147/COPD.S138457</pub-id><pub-id pub-id-type="pmid">28790810</pub-id><pub-id pub-id-type="pmcid">PMC5529299</pub-id></element-citation></ref><ref id="B113-cimb-45-00324"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghio</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Hilborn</surname><given-names>E.D.</given-names></name><name name-style="western"><surname>Stonehuerner</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Dailey</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Carter</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Richards</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Crissman</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Foronjy</surname><given-names>R.F.</given-names></name><name name-style="western"><surname>Uyeminami</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Pinkerton</surname><given-names>K.E.</given-names></name></person-group><article-title>Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect</article-title><source>Am. J. Respir. Crit. Care. Med.</source><year>2008</year><volume>178</volume><fpage>1130</fpage><lpage>1138</lpage><pub-id pub-id-type="doi">10.1164/rccm.200802-334OC</pub-id><pub-id pub-id-type="pmid">18723436</pub-id></element-citation></ref><ref id="B114-cimb-45-00324"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zajac</surname><given-names>D.</given-names></name></person-group><article-title>Mineral micronutrients in asthma</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><elocation-id>4001</elocation-id><pub-id pub-id-type="doi">10.3390/nu13114001</pub-id><pub-id pub-id-type="pmid">34836256</pub-id><pub-id pub-id-type="pmcid">PMC8625329</pub-id></element-citation></ref><ref id="B115-cimb-45-00324"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fahmy</surname><given-names>B.</given-names></name><name name-style="western"><surname>Cormier</surname><given-names>S.A.</given-names></name></person-group><article-title>Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells</article-title><source>Toxicol. Vitr.</source><year>2009</year><volume>23</volume><fpage>1365</fpage><lpage>1371</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2009.08.005</pub-id><pub-id pub-id-type="pmid">19699289</pub-id><pub-id pub-id-type="pmcid">PMC2756312</pub-id></element-citation></ref><ref id="B116-cimb-45-00324"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J.-W.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>I.-C.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>N.-R.</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>C.-M.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>O.-K.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>J.-W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.-C.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S.-R.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>I.-S.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>K.-S.</given-names></name></person-group><article-title>Copper oxide nanoparticles aggravate airway inflammation and mucus production in asthmatic mice via MAPK signaling</article-title><source>Nanotoxicology</source><year>2016</year><volume>10</volume><fpage>445</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.3109/17435390.2015.1078851</pub-id><pub-id pub-id-type="pmid">26472121</pub-id></element-citation></ref><ref id="B117-cimb-45-00324"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sagdic</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sener</surname><given-names>O.</given-names></name><name name-style="western"><surname>Bulucu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Karadurmus</surname><given-names>N.</given-names></name><name name-style="western"><surname>&#214;zel</surname><given-names>H.E.</given-names></name><name name-style="western"><surname>Yamanel</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tasci</surname><given-names>C.</given-names></name><name name-style="western"><surname>Naharci</surname><given-names>I.</given-names></name><name name-style="western"><surname>Ocal</surname><given-names>R.</given-names></name></person-group><article-title>Aydin Oxidative stress status and plasma trace elements in patients with asthma or allergic rhinitis</article-title><source>Allergol. Immunopathol.</source><year>2011</year><volume>39</volume><fpage>200</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.aller.2010.07.006</pub-id><pub-id pub-id-type="pmid">21550164</pub-id></element-citation></ref><ref id="B118-cimb-45-00324"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>C.-H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>P.-J.</given-names></name><name name-style="western"><surname>Hsia</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>C.-J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P.-C.</given-names></name></person-group><article-title>Role of certain trace minerals in oxidative stress, inflammation, CD4/CD8 lymphocyte ratios and lung function in asthmatic patients</article-title><source>Ann. Clin. Biochem.</source><year>2011</year><volume>48</volume><fpage>344</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1258/acb.2011.010266</pub-id><pub-id pub-id-type="pmid">21546427</pub-id></element-citation></ref><ref id="B119-cimb-45-00324"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>W.</given-names></name></person-group><article-title>Association between trace elements levels and asthma susceptibility</article-title><source>Respir. Med.</source><year>2018</year><volume>145</volume><fpage>110</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2018.10.028</pub-id><pub-id pub-id-type="pmid">30509699</pub-id></element-citation></ref><ref id="B120-cimb-45-00324"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richter</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cantin</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Beaulieu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cloutier</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lariv&#233;e</surname><given-names>P.</given-names></name></person-group><article-title>Zinc chelators inhibit eotaxin, RANTES, and MCP-1 production in stimulated human airway epithelium and fibroblasts</article-title><source>Am. J. Physiol. Lung Cell Mol. Physiol.</source><year>2003</year><volume>285</volume><fpage>L719</fpage><lpage>L729</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00406.2002</pub-id><pub-id pub-id-type="pmid">12765881</pub-id></element-citation></ref><ref id="B121-cimb-45-00324"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Murgia</surname><given-names>C.</given-names></name><name name-style="western"><surname>Leong</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>L.-W.</given-names></name><name name-style="western"><surname>Perozzi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Knight</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ruffin</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zalewski</surname><given-names>P.</given-names></name></person-group><article-title>Anti-inflammatory effects of zinc and alterations in zinc transporter mRNA in mouse models of allergic inflammation</article-title><source>Am. J. Physiol. Lung. Cell. Mol. Physiol.</source><year>2007</year><volume>292</volume><fpage>L577</fpage><lpage>L584</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00280.2006</pub-id><pub-id pub-id-type="pmid">17085522</pub-id></element-citation></ref><ref id="B122-cimb-45-00324"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>G.</given-names></name></person-group><article-title>Zinc suppressed the airway inflammation in asthmatic rats: Effects of zinc on generation of eotaxin, MCP-1, IL-8, IL-4, and IFN-&#947;</article-title><source>Biol. Trace. Elem. Res.</source><year>2012</year><volume>150</volume><fpage>314</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1007/s12011-012-9493-7</pub-id><pub-id pub-id-type="pmid">22932891</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="cimb-45-00324-t001" orientation="portrait"><object-id pub-id-type="pii">cimb-45-00324-t001_Table 1</object-id><label>Table 1</label><caption><p>Antioxidants and asthma risk in relation to smoking status.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Population</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antioxidants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Findings</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="2" align="center" valign="middle" colspan="1">Cross-sectional</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 2112 <sup>1</sup>2th grade US students</td><td rowspan="2" align="center" valign="middle" colspan="1">VC, VE (diet)</td><td align="center" valign="middle" rowspan="1" colspan="1">Low dietary VC intake (&lt;110 mg/day) was associated with FEV<sub>1</sub> decline and respiratory symptoms in smokers with asthma</td><td rowspan="2" align="center" valign="middle" colspan="1">[<xref rid="B32-cimb-45-00324" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Smokers = 515</td><td align="center" valign="middle" rowspan="1" colspan="1">VE intake was not associated with asthma</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Cross-sectional</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Total subjects = 13,039 US adults (20&#8211;80 yrs)</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Total carotenoids (diet and supplement)</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">High intake of carotenoids (&#8805;165.59 &#956;g/kg/day) was associated with reduced asthma risk in nonsmokers (OR = 0.63, 95% CI = 0.42 to 0.93), current smokers (OR = 0.54, 95% CI = 0.36 to 0.83), and ex-smokers (OR = 0.64, 95% CI = 0.42 to 0.97)</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">[<xref rid="B33-cimb-45-00324" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Current asthma = 1784; non-current asthma = 11,255</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nonsmokers= 7106; current smokers= 3304; ex-smokers= 2624</td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">RDBPC</td><td rowspan="2" align="center" valign="middle" colspan="1">Total subjects = 72 UK nonsmoking asthmatics (18&#8211;60 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">VE (supplement)</td><td rowspan="2" align="center" valign="middle" colspan="1">VE had no beneficial effects on asthma</td><td rowspan="2" align="center" valign="middle" colspan="1">[<xref rid="B34-cimb-45-00324" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">500 mg VE capsules (D-&#945;-tocopherol) in soya bean oil or matched placebo (capsules, gelatine base) for 6 weeks</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">RDBPC</td><td rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Total subjects = 197 UK smoking and nonsmoking asthmatics (18&#8211;54 yrs)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Se (supplement)</td><td rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Plasma Se was increased by 48% in the Se group. However, no significant improvement in QoL score was observed in the Se group compared with placebo</td><td rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">[<xref rid="B35-cimb-45-00324" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 &#956;g/day high-Se yeast preparation or matched placebo (yeast only) for 24 weeks</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: RDBPC, randomized double blind placebo control; VC, vitamin C; VE, vitamin E; Se, selenium; QoL, quality of life; OR, odds ratio.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="cimb-45-00324-t002" orientation="portrait"><object-id pub-id-type="pii">cimb-45-00324-t002_Table 2</object-id><label>Table 2</label><caption><p>OS biomarkers in smoking and nonsmoking asthmatics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Population</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OS Biomarkers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-control study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total subjects = 210 Indian (13&#8211;80 yrs) Smokers/nonsmokers (asthmatics = 19/101; healthy controls = 29/61)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic smokers = MDA &#8593;, FRAP &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-cimb-45-00324" ref-type="bibr">37</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 194 Italian patients with different pulmonary diseases (average 45.8 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic current smokers = MDA &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B38-cimb-45-00324" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatics (current and ex-smokers) = 64; healthy controls (nonsmokers) = 14</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 329 Tunisian adults (average 43.6 yrs)</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic current smokers = Protein carbonyls, peroxynitrite &#8593;</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B39-cimb-45-00324" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic current smokers/healthy controls = 14/73; Asthmatic ex- smokers/healthy controls = 17/13</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers/healthy controls = 120/92</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 266 Chinese adults (39&#8211;47 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic smokers and nonsmokers = SOD, GSH &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B40-cimb-45-00324" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic smokers/nonsmokers = 25/106; healthy controls (nonsmokers) = 135</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Total subjects = 61 Indian (15&#8211;40 yrs) Asthmatic nonsmokers/healthy controls= 38/23</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic nonsmokers = SOD, NO<sub>2</sub><sup>&#8722;</sup>, protein carbonyls, lipid peroxide &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B41-cimb-45-00324" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GPx, protein sulfhydrils &#8595;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 32 Turkish adults (average 41 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic nonsmokers = GSH, NO<sub>2</sub><sup>&#8722;</sup> &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B42-cimb-45-00324" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stable asthmatic nonsmokers = 11; Severe asthmatic nonsmokers = 10; Healthy nonsmokers = 11</td></tr></tbody></table><table-wrap-foot><fn><p>(&#8595;) decrease, (&#8593;) increase.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="cimb-45-00324-t003" orientation="portrait"><object-id pub-id-type="pii">cimb-45-00324-t003_Table 3</object-id><label>Table 3</label><caption><p>Inflammatory biomarkers in smoking and nonsmoking asthmatics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Population</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Inflammation Biomarkers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 143 Greek adults (average 48.7 yrs)</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic smokers = FeNo &#8595;, eosinophils &#8593;</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B43-cimb-45-00324" ref-type="bibr">43</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic smokers/nonsmokers = 40/43</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy smokers/nonsmokers = 30/30</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 470 Belgium adults (average 41 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic smokers = FeNo &#8595;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B44-cimb-45-00324" ref-type="bibr">44</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic smokers/nonsmokers = 59/411</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 147 European adults (average 46.8 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic smokers = FeNo &#8595;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B45-cimb-45-00324" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic smokers = 18; Severe Asthmatic nonsmokers = 49; Mild-moderate asthmatic nonsmokers = 36; healthy nonsmoker = 44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers = FeNo, eosinophil &#8593;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 1230 Italian adults (20&#8211;65 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic nonsmokers = FeNo, eosinophils, neutrophils &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B46-cimb-45-00324" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Current/past asthmatic nonsmokers = 404/185; Current and past chronic bronchitis smokers = 92; healthy controls = 549</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 282 Danish (14&#8211;44 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic nonsmokers = FeNo, &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B47-cimb-45-00324" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic current/ex-smokers = 112/62; Asthmatic nonsmokers = 108</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 58 Polish adults (25&#8211;45 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic nonsmokers = FeNo, eotaxin, eosinophil &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B48-cimb-45-00324" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers/Healthy controls = 46/12</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 68 Lithuanian adults (average 55.2 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic smokers = Eotaxin, neutrophils, eosinophils &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B49-cimb-45-00324" ref-type="bibr">49</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic smokers/nonsmokers = 19/26; Healthy smokers and non-smokers = 23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers = Eotaxin, neutrophils, eosinophils, IL-5 &#8593;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 86 UK adults (average 50 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic smokers = IL-1&#946;, IL-5, IL-18R1 &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B50-cimb-45-00324" ref-type="bibr">50</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Severe asthmatic smokers/nonsmokers = 21/37; mild-moderate asthmatics = 15; healthy controls = 13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers = Eotaxin, IL-4, IL-5, IL-1&#946;, IL-1RL1, IL-1R1, NLRP3 &#8593;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 97 UK adults (average 37 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic smokers = eosinophils, ECP, neutrophils, IL-8 &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B51-cimb-45-00324" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic smokers/nonsmokers = 31/36; Nonasthmatic smokers/nonsmokers = 15/15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers = eosinophils, ECP &#8593;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 152 UK adults (18&#8211;75 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic smokers = Periostin &#8595;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B52-cimb-45-00324" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic smokers/nonsmokers = 56/51; Healthy smokers/nonsmokers = 20/25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers = Periostin &#8593;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 89 Turkish adults (25&#8211;65 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic nonsmokers = Periostin, TNF&#945;, IL-4, IL-5, YKL-40 &#8593;, IL-37 &#8595;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B53-cimb-45-00324" ref-type="bibr">53</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers/healthy controls = 59/30</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 79 Greek adults (average 46 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic smokers = eosinophils, neutrophils &#8593;, IL-18 &#8595;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B54-cimb-45-00324" ref-type="bibr">54</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic smokers/nonsmokers = 24/22; Healthy smokers/nonsmokers = 16/17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers = eosinophils, neutrophils, IL-18 &#8593;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 115 Korean adults (average 55 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic smokers = ILC3, eosinophils, neutrophils &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B55-cimb-45-00324" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic smokers/nonsmokers = 58/33; Healthy smokers/nonsmokers = 11/13</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 168 Chinese adults (average 36 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Eosinophilic asthmatic nonsmokers = ILC2, IgE, eosinophils, FeNO &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B56-cimb-45-00324" ref-type="bibr">56</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eosinophilic asthmatic/non asthmatic nonsmokers = 62/64; Healthy controls = 42</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 85 Japanese adults (20&#8211;60 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic nonsmokers = hs-CRP, eosinophils, neutrophils &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B57-cimb-45-00324" ref-type="bibr">57</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers/healthy controls = 45/40</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 98 Iranian adults (average 35 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic nonsmokers = hs-CRP, eosinophils &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B58-cimb-45-00324" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers receiving/not receiving inhaled fluticasone (500 &#181;g/day) = 31/30; Healthy controls = 37</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 525 European adults (36&#8211;55 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic smokers and nonsmokers = hs-CRP, eosinophils, neutrophils, IgE &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B59-cimb-45-00324" ref-type="bibr">59</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Smokers or ex-smokers with severe asthma = 95; Nonsmokers with severe asthma = 263; Nonsmokers with mild-moderate asthma = 76; healthy nonsmoker = 91</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Case-control study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 88 European adults (39&#8211;50 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic ex-smokers = MMP-12, CXCL8, neutrophil elastase, AZU-1, PPBP &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B60-cimb-45-00324" ref-type="bibr">60</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic current smokers = 11; Asthmatic ex-smokers = 22; Asthmatic nonsmoker s = 37; Healthy nonsmoker = 18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers = eosinophil &#8593;</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Cross-sectional study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 324 European adults with severe asthma (average 52.5 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic current smokers = FeNo &#8595;, NOS<sub>2</sub>, NOx<sub>2</sub> &#8593;</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B61-cimb-45-00324" ref-type="bibr">61</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Current smokers = 42; Ex-smokers = 112; Nonsmokers = 260</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic ex-smokers = FeNo, NOX<sub>2</sub> &#8593;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers = FeNo &#8593;</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Cross-sectional study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 740 UK patients with severe asthma (6&#8211;43 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic current smokers = FeNO, blood eosinophils, sputum eosinophils</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B62-cimb-45-00324" ref-type="bibr">62</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Current smokers = 69; Ex-smokers = 210; Nonsmokers = 461</td><td align="center" valign="middle" rowspan="1" colspan="1">sputum neutrophils, IgE &#8595;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic ex-smokers = FeNO, sputum neutrophils, blood eosinophils &#8593;, IgE &#8595;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers = FeNO, IgE, sputum neutrophils, sputum eosinophils, blood eosinophils &#8593;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Cross-sectional study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 1578 French patients with asthma (40&#8211;64 yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">Asthmatic current and ex- smokers = FeNO &#8595;, blood eosinophils &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B63-cimb-45-00324" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Current smokers = 294; Ex-smokers = 473; Nonsmokers = 812</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthmatic nonsmokers = FeNO &#8593;, blood eosinophils &#8595;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Cross-sectional study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 274 Greek patients with asthma (average 50 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic smokers and nonsmokers = FeNO &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B64-cimb-45-00324" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhaled corticosteroid (ICS)-treated smokers = 50; ICS-untreated smokers = 32; ICS-treated nonsmokers = 144; ICS-untreated nonsmokers = 48</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Cross-sectional study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 478 Chinese patients with asthma (average 45 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic nonsmokers = IgE &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B65-cimb-45-00324" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Obstructive group (current smokers = 70; ex-smokers = 44; nonsmokers = 271), Normal group (current smokers = 9; ex-smokers = 6; nonsmokers = 78)</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Prospective cohort study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 4257 European and Australian adults (average 54 yrs)</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic nonsmokers = FeNO &#8593;</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B66-cimb-45-00324" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Current asthma (smokers = 97; nonsmokers = 554)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-asthma (smokers = 651; nonsmokers = 2955)</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Prospective cohort study</td><td align="center" valign="middle" rowspan="1" colspan="1">Total subjects = 45 Italian adults with severe asthma (average 60 yrs)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Asthmatic nonsmokers = FeNO, periostin, eosinophil, TGF-&#946;1 &#8593;</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B67-cimb-45-00324" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nonsmokers = 42; ex-smokers = 3</td></tr></tbody></table><table-wrap-foot><fn><p>(&#8595;) decrease, (&#8593;) increase.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="cimb-45-00324-t004" orientation="portrait"><object-id pub-id-type="pii">cimb-45-00324-t004_Table 4</object-id><label>Table 4</label><caption><p>Potential influence of antioxidant vitamins and minerals on CS-induced asthma biomarkers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant Vitamins/Minerals</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Concentration/Supplement Intake</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OS Biomarkers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Inflammation Biomarkers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VA (RAR&#947;, ATRA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;1000 &#956;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMPs (MMP8, MMP9) &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B69-cimb-45-00324" ref-type="bibr">69</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VA (ATRA, 9-<italic toggle="yes">cis</italic> RA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 mM in the presence of 0.2 mg/mL neutralizing anti-TGF-&#946;1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMP9 &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-cimb-45-00324" ref-type="bibr">70</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VA (RA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5, 15, 50 &#956;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF&#945;, IL-6 &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-cimb-45-00324" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VA (ATRA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">400 &#956;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-4, IL-5, IL-17A, neutrophils, eosinophils &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-cimb-45-00324" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VA (ATRA, 9-<italic toggle="yes">cis</italic> RA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10<sup>&#8722;6</sup>&#8211;10<sup>&#8722;10</sup> M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-4, eotaxin &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-cimb-45-00324" ref-type="bibr">74</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lycopene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.16 mg (equivalent to 8 mg/kg per day) plus 0.05 mg VE and 0.006 mg &#946;-carotene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-4, IL-5, eosinophils &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B81-cimb-45-00324" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lycopene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3, 5 10 &#956;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GSH &#8593;, ROS, H<sub>2</sub>O<sub>2</sub> &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-cimb-45-00324" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo/vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BCX</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;4 &#956;M (in vitro)<break/>30&#8722;43 nmol BCX/g liver (in vivo)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutrophils, TNF&#945;, IL-6, MMPs (MMP2, MMP9) &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-cimb-45-00324" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1500 mg/day for 2 weeks, or a placebo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FeNO &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-cimb-45-00324" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">130 mg VC/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eosinophils &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-cimb-45-00324" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-randomized trial in vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1500 IU/day for 16 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-3, IL-4 &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-cimb-45-00324" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ex-vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1200 mg/day for 8 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF&#945;, IL-1&#946;, IL-6 &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-cimb-45-00324" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RDBPC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1200 mg/day for 14 days, or a placebo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eosinophils, neutrophils &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-cimb-45-00324" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 mg VE/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub>, ROS &#8595;, GSH, SOD &#8593;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-5, IL-13, eosinophils, neutrophils &#8595;,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B94-cimb-45-00324" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2 and 2.0 mg VE/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ROS &#8595;, GSH &#8593;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-4, IgE &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-cimb-45-00324" ref-type="bibr">95</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5, 10, 15, and 20 IU VE/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO<sub>2</sub><sup>&#8722;</sup>, peroxynitrite &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-4, IL-5, IL-13, eotaxin, IgE, TGF-&#946;1 &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-cimb-45-00324" ref-type="bibr">96</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2 or 2 mg VE/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-5, IL-12, IL-13 &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B97-cimb-45-00324" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 &#956;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6, CXCL8 &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-cimb-45-00324" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25 &#956;g/day calcitriol for 6 months, or a placebo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-5, IL-9, IL-13, IgE, eosinophils &#8595;, IL-10 &#8593;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-cimb-45-00324" ref-type="bibr">100</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 &#956;g/kg VD/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO<sub>2</sub><sup>&#8722;</sup> &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-4 &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-cimb-45-00324" ref-type="bibr">101</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100, 500, or 1000 IU VD/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6, IL-17 &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-cimb-45-00324" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10,000 IU VD/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IgE &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B103-cimb-45-00324" ref-type="bibr">103</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2280 IU VD/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-5, IL-13, eosinophils, neutrophils &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-cimb-45-00324" ref-type="bibr">104</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 mg VD/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IgE &#8595;, IL-10 &#8593;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B105-cimb-45-00324" ref-type="bibr">105</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10,000 IU VD/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6, IL-17, TNF&#945;, eosinophils &#8595;, IL-10 &#8593;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B106-cimb-45-00324" ref-type="bibr">106</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 &#956;g/mL/20 g VD/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6, IL-1&#946;, TNF&#945;, &#8595;, IL-10 &#8593;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B107-cimb-45-00324" ref-type="bibr">107</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fe</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.3 M plus ferroptosis inhibitor Fer-1 (0.1 &#956;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDA, ROS &#8593;, GSH &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6 &#8593;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-cimb-45-00324" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zn</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 &#956;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF&#945;, eotaxin &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-cimb-45-00324" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zn</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0, 54, or 100 &#956;g Zn/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eosinophils &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B121-cimb-45-00324" ref-type="bibr">121</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zn</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95 mg Zn/kg bw/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eosinophils, neutrophils, eotaxin &#8595;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-cimb-45-00324" ref-type="bibr">122</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: RDBPC, randomized double blind placebo control; RCT, randomized controlled trial; VA, vitamin A; ATRA, All-<italic toggle="yes">trans</italic> RA; RA, retinoic acid; RAR, retinoic acid receptors; BCX, &#946;-cryptoxanthin; VC, vitamin C; VE, vitamin E; VD, vitamin D; Fe, iron; Zn, zinc. (&#8595;) decrease, (&#8593;) increase.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>